Ptgs2 (prostaglandin-endoperoxide synthase 2) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Behavioral & Substance Use Disorder Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: Ptgs2 (prostaglandin-endoperoxide synthase 2) Rattus norvegicus
Analyze
Symbol: Ptgs2
Name: prostaglandin-endoperoxide synthase 2
RGD ID: 620349
Description: Enables oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen. Involved in several processes, including learning or memory; modulation of chemical synaptic transmission; and positive regulation of cytokine production. Acts upstream of or within bone mineralization. Located in caveola and cytoplasm. Part of protein-containing complex. Used to study several diseases, including brain disease (multiple); hypertension (multiple); liver disease (multiple); lung disease (multiple); and neurodegenerative disease (multiple). Biomarker of several diseases, including carcinoma (multiple); glioblastoma (multiple); inflammatory bowel disease (multiple); pleurisy; and type 2 diabetes mellitus. Human ortholog(s) of this gene implicated in several diseases, including arthritis (multiple); avian influenza; cardiovascular system disease (multiple); liver disease (multiple); and lung disease (multiple). Orthologous to human PTGS2 (prostaglandin-endoperoxide synthase 2); PARTICIPATES IN pro-inflammatory cytokine mediated pathway; acetylsalicylic acid pharmacodynamics pathway; antipyrine drug pathway; INTERACTS WITH (+)-pilocarpine; (-)-epigallocatechin 3-gallate; (1->4)-beta-D-glucan.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: COX-2; Cox2; cyclooxygenase 2; cyclooxygenase-2; PGH synthase 2; PGHS-2; Pghs2; PHS II; prostaglandin G/H synthase 2; prostaglandin H2 synthase 2
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Black Rat
Alliance Orthologs
More Info more info ...
Allele / Splice: Ptgs2em1Mcwi ; Ptgs2em2Mcwi
Genetic Models: SS-Ptgs2em1Mcwi ; SS-Ptgs2em2Mcwi
Candidate Gene For: Bp329
Latest Assembly: GRCr8 - GRCr8 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81364,714,063 - 64,722,320 (+)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl1364,713,619 - 64,722,320 (+)EnsemblGRCr8
mRatBN7.21362,163,936 - 62,172,193 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1362,163,932 - 62,172,188 (+)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx1364,798,537 - 64,804,239 (+)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01366,083,346 - 66,089,057 (+)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01363,344,882 - 63,350,588 (+)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.01367,351,230 - 67,356,920 (+)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1367,351,087 - 67,359,335 (+)Ensemblrn6Rnor6.0
Rnor_5.01372,315,959 - 72,324,483 (+)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.41364,427,288 - 64,432,978 (+)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera1362,129,439 - 62,135,131 (+)NCBICelera
RGSC_v3.11364,441,245 - 64,449,480 (+)NCBI
Cytogenetic Map13q21NCBI
JBrowse:




Disease Annotations     Click to see Annotation Detail View
abdominal aortic aneurysm  (ISO)
acute kidney failure  (IMP)
Acute Liver Failure  (IMP,ISO)
Acute Lung Injury  (IEP,ISO)
adenocarcinoma  (IMP,ISO)
Adrenal Gland Neoplasms  (ISO)
Albuminuria  (ISO)
Alcohol Withdrawal Delirium  (ISO)
allergic rhinitis  (ISO)
Alzheimer's disease  (IMP,ISO)
amyotrophic lateral sclerosis  (ISO)
Anaphylaxis  (IMP,ISO)
Anorexia  (IMP)
arteriosclerosis  (ISO)
asphyxia neonatorum  (ISO)
aspirin-induced respiratory disease  (ISO)
asthma  (IEP,ISO)
atherosclerosis  (ISO)
autistic disorder  (ISO)
avian influenza  (ISO)
B-Cell Chronic Lymphocytic Leukemia  (ISO)
B-cell lymphoma  (ISO)
Barrett's esophagus  (IMP,ISO)
bipolar disorder  (ISO)
bladder neck obstruction  (ISO)
Bone Fractures  (IMP)
Bone Neoplasms  (ISO)
Brain Injuries  (IMP,ISO)
brain ischemia  (IDA,IEP,ISO)
Breast Neoplasms  (ISO)
Burns  (ISO)
Cachexia  (ISO)
Calcification of Aortic Valve  (ISO)
carcinoma  (ISO)
Cardiac Arrhythmias  (ISO)
cardiomyopathy  (ISO)
cardiovascular system disease  (ISO)
Cerebral Hemorrhage  (IEP,ISO)
cervix uteri carcinoma in situ  (ISO)
Chagas disease  (ISO)
Chemical and Drug Induced Liver Injury  (IEP,ISO)
cholangiocarcinoma  (ISO)
chronic obstructive pulmonary disease  (ISO)
chronic rhinosinusitis with nasal polyps  (ISO)
cognitive disorder  (ISO)
colitis  (IEP,ISO)
Colonic Neoplasms  (IMP,ISO)
Colorectal Neoplasms  (ISO)
congestive heart failure  (ISO)
coronary artery disease  (ISO)
Cough  (ISO)
COVID-19  (ISO)
Creutzfeldt-Jakob disease  (ISO)
Crohn's disease  (IEP)
cryptorchidism  (ISO)
cystic fibrosis  (ISO)
cystitis  (IMP)
demyelinating disease  (ISO)
depressive disorder  (ISO)
diabetes mellitus  (ISO)
Diabetic Nephropathies  (IMP)
diabetic neuropathy  (IEP,IMP)
disease of cellular proliferation  (ISO)
Drug-Related Side Effects and Adverse Reactions  (ISO)
ductal carcinoma in situ  (ISO)
duodenal ulcer  (ISO)
Edema  (ISO)
end stage renal disease  (ISO)
Endometrial Neoplasms  (ISO)
endometriosis  (IDA,IMP,ISO)
Endotoxemia  (IEP)
Esophageal Neoplasms  (IEP,ISO)
esophagitis  (ISO)
esophagus adenocarcinoma  (ISO)
esophagus squamous cell carcinoma  (ISO)
Experimental Arthritis  (IEP,IMP,ISO)
Experimental Autoimmune Encephalomyelitis  (IEP,ISO)
Experimental Autoimmune Neuritis  (IEP)
Experimental Diabetes Mellitus  (IEP,ISO)
Experimental Liver Cirrhosis  (ISO)
Experimental Mammary Neoplasms  (IEP,IMP,ISO)
Experimental Radiation Injuries  (IEP)
Experimental Seizures  (IEP)
familial adenomatous polyposis  (ISO)
Fetal Growth Retardation  (IEP)
Fever  (IMP,ISO)
Fibrosis  (IMP,ISO)
Gallbladder Neoplasms  (ISO)
gastric ulcer  (IMP,ISO)
gastritis  (IMP)
gastroesophageal reflux disease  (ISO)
glioblastoma  (IEP,ISO)
gliosarcoma  (IEP)
granulosa cell tumor  (ISO)
Graves ophthalmopathy  (ISO)
growth hormone secreting pituitary adenoma  (ISO)
head and neck squamous cell carcinoma  (ISO)
hepatocellular carcinoma  (IEP,ISO)
high grade glioma  (ISO)
human immunodeficiency virus infectious disease  (IEP)
Human Influenza  (ISO)
Huntington's disease  (IMP)
hydronephrosis  (ISO)
Hyperalgesia  (IMP,ISO)
Hyperemia  (ISO)
hyperglycemia  (ISO)
Hyperplasia  (ISO)
hypertension  (IAGP,ISO)
Hypoxia  (ISO)
idiopathic pulmonary fibrosis  (ISO)
in situ carcinoma  (ISO)
Inflammation  (IMP,ISO)
inflammatory bowel disease  (ISO)
intestinal obstruction  (IEP)
Intestinal Polyps  (ISO)
invasive ductal carcinoma  (ISO)
kidney disease  (ISO)
Kidney Neoplasms  (ISO)
Laryngeal Neoplasms  (ISO)
Laryngeal Papillomatosis  (ISO)
Left Ventricular Hypertrophy  (IMP)
leiomyosarcoma  (ISO)
liver cirrhosis  (ISO)
lung cancer  (IMP)
lung disease  (ISO)
lung non-small cell carcinoma  (ISO)
Lymphatic Metastasis  (ISO)
meconium aspiration syndrome  (IEP)
melanoma  (ISO)
metabolic dysfunction-associated steatotic liver disease  (ISO)
Metabolic Syndrome  (IEP)
mouth disease  (ISO)
Mouth Neoplasms  (IMP,ISO)
myocardial infarction  (ISO)
Myocardial Reperfusion Injury  (IMP)
myocarditis  (ISO)
Nasal Polyps  (ISO)
Neoplasm Metastasis  (IMP,ISO)
Neoplasm Recurrence, Local  (ISO)
nephroblastoma  (ISO)
nephrotic syndrome  (IMP)
nervous system disease  (ISO)
Neurogenic Inflammation  (ISO)
obesity  (ISO)
obstructive sleep apnea  (ISO)
occupational asthma  (ISO)
open-angle glaucoma  (ISO)
oral mucosa leukoplakia  (ISO)
oral submucous fibrosis  (ISO)
osteoarthritis  (ISO)
Ovarian Neoplasms  (ISO)
Pain  (IEP,IMP,ISO)
pancreatic cancer  (ISO)
pancreatic ductal carcinoma  (ISO)
pancreatitis  (ISO)
papilloma  (ISO)
Parkinsonism  (IDA,ISO)
pericardial effusion  (ISO)
Peripheral Nerve Injuries  (IEP,ISO)
pleurisy  (IDA,IEP)
polycystic kidney disease  (IMP)
portal hypertension  (IMP)
pre-malignant neoplasm  (ISO)
Precocious Puberty  (ISO)
Premature Birth  (ISO)
prolactinoma  (ISO)
prostate cancer  (ISO)
prostate carcinoma in situ  (ISO)
prostatic hypertrophy  (ISO)
Prostatic Neoplasms  (ISO)
prostatitis  (IEP)
proteinuria  (ISO)
pulmonary emphysema  (IMP)
pulmonary fibrosis  (IEP,ISO)
pulmonary hypertension  (IMP,ISO)
renal cell carcinoma  (IEP,ISO)
Reperfusion Injury  (IDA,IEP,IMP,ISO)
retrograde amnesia  (IMP)
rheumatoid arthritis  (ISO)
sarcoidosis  (ISO)
schizophrenia  (IEP)
secondary hyperparathyroidism  (IMP,ISO)
Sepsis-Associated Encephalopathy  (IEP)
skin disease  (ISO)
Skin Neoplasms  (ISO)
Sleep Deprivation  (ISO)
Spinal Cord Injuries  (IEP)
squamous cell carcinoma  (ISO)
status epilepticus  (IMP,ISO)
steatotic liver disease  (IMP)
Stomach Neoplasms  (ISO)
stroke  (ISO)
Subarachnoid Hemorrhage  (ISO)
systemic lupus erythematosus  (ISO)
systemic scleroderma  (ISO)
thrombosis  (ISO)
Thyroid Neoplasms  (ISO)
Tongue Neoplasms  (ISO)
transitional cell carcinoma  (ISO)
traumatic brain injury  (ISO)
type 2 diabetes mellitus  (IEP)
ulcerative colitis  (IMP)
urinary bladder cancer  (ISO)
Urologic Neoplasms  (ISO)
Uterine Cervical Neoplasms  (ISO)
Ventilator-Induced Lung Injury  (IMP)
Wernicke encephalopathy  (IMP)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-alpha-viniferin  (ISO)
(+)-artemisinin  (ISO)
(+)-catechin  (ISO)
(+)-isolariciresinol  (ISO)
(+)-pilocarpine  (EXP,ISO)
(+)-pinoresinol  (ISO)
(+)-syringaresinol  (ISO)
(+)-syringaresinol beta-D-glucoside  (ISO)
(+)-taxifolin  (ISO)
(-)-Arctigenin  (ISO)
(-)-citrinin  (ISO)
(-)-epigallocatechin 3-gallate  (EXP,ISO)
(-)-matairesinol  (ISO)
(1->4)-beta-D-glucan  (EXP)
(1S)-bornane-2,3-dione  (ISO)
(20S)-ginsenoside Rh1  (ISO)
(24S)-24-hydroxycholesterol  (ISO)
(25R)-cholest-5-ene-3beta,26-diol  (ISO)
(4-oxo-3-\{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl\}-3,4-dihydrophthalazin-1-yl)acetic acid  (ISO)
(4Z,7Z,10Z,13Z,15E,19Z)-17-hydroxydocosahexaenoic acid  (ISO)
(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoic acid  (EXP)
(E)-thiamethoxam  (ISO)
(R)-adrenaline  (ISO)
(R)-amygdalin  (ISO)
(R)-lipoic acid  (EXP)
(R)-noradrenaline  (EXP)
(R,R,R)-alpha-tocopherol  (EXP,ISO)
(S)-amphetamine  (ISO)
(S)-colchicine  (ISO)
(S)-naringenin  (EXP,ISO)
(S)-nicotine  (EXP,ISO)
1'-acetoxychavicol acetate  (ISO)
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane  (EXP,ISO)
1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene  (EXP,ISO)
1,2,4-trimethylbenzene  (EXP,ISO)
1,2-dimethylhydrazine  (EXP,ISO)
1,2-dioctanoyl-sn-glycero-3-phosphate  (ISO)
1,2-naphthoquinone  (ISO)
1,3,5-trinitrobenzene  (ISO)
1,3-dichloropropan-2-ol  (ISO)
1,4-bis(2-ethylhexyl) sulfosuccinate  (ISO)
1,4-dithiothreitol  (ISO)
1,4-phenylenediamine  (ISO)
1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone  (ISO)
1-(5-isoquinolinesulfonyl)-2-methylpiperazine  (ISO)
1-bromopropane  (ISO)
1-chloro-2,4-dinitrobenzene  (ISO)
1-fluoro-2,4-dinitrobenzene  (ISO)
1-hydroxy-2-naphthoic acid  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (EXP,ISO)
1-methylnicotinamide  (EXP)
1-naphthyl isothiocyanate  (ISO)
1-O-palmitoyl-2-O-(5-oxovaleryl)-sn-glycero-3-phosphocholine  (ISO)
1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester  (ISO)
1-Phenyl-6,7-dihydroxy-isochroman  (ISO)
11-deoxycorticosterone  (EXP)
11-deoxyprostaglandin E1  (ISO)
12(S)-HPETE  (ISO)
15-acetyldeoxynivalenol  (ISO)
15-deoxy-Delta(12,14)-prostaglandin J2  (ISO)
16,16-dimethylprostaglandin E2  (EXP,ISO)
17-hydroxyjolkinolide B  (ISO)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (EXP)
17beta-hydroxy-5alpha-androstan-3-one  (ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (EXP,ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (ISO)
2,2',4,4'-tetrachlorobiphenyl  (ISO)
2,2-(2-Chlorophenyl-4'-chlorophenyl)-1,1-dichloroethene  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3-bis(4-hydroxyphenyl)propionitrile  (EXP)
2,4,6-trinitrobenzenesulfonic acid  (EXP,ISO)
2,4-D  (EXP)
2,4-diaminotoluene  (ISO)
2,4-dibromophenyl 2,4,5-tribromophenyl ether  (ISO)
2,6-di-tert-butyl-4-methylphenol  (EXP,ISO)
2-(4-hydroxyphenyl)ethanol  (ISO)
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine  (ISO)
2-[4-[3-[2-(trifluoromethyl)-9-thioxanthenylidene]propyl]-1-piperazinyl]ethanol  (ISO)
2-acetamidofluorene  (EXP)
2-acetyl-1-alkyl-sn-glycero-3-phosphocholine  (ISO)
2-acetyloxy-4-(trifluoromethyl)benzoic acid  (EXP,ISO)
2-amino-2-deoxy-D-galactopyranose  (EXP,ISO)
2-amino-2-deoxy-D-glucopyranose  (EXP,ISO)
2-aminobiphenyl  (ISO)
2-arachidonoylglycerol  (ISO)
2-butoxyethanol  (ISO)
2-hydroxy-17beta-estradiol  (ISO)
2-Hydroxy-4-trifluoromethyl benzoic acid  (ISO)
2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid  (ISO)
2-hydroxypropanoic acid  (ISO)
2-methoxy-17beta-estradiol  (ISO)
2-Methoxy-4-methylphenol  (ISO)
2-palmitoylglycerol  (ISO)
2-tert-butylhydroquinone  (EXP,ISO)
22-Hydroxycholesterol  (ISO)
26-hydroxycholesterol  (ISO)
3',5'-cyclic AMP  (EXP)
3',5'-di-O-methyltricetin  (ISO)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (EXP,ISO)
3,3',4,4',5-pentachlorobiphenyl  (EXP,ISO)
3,3',5,5'-tetrabromobisphenol A  (ISO)
3,3',5-triiodo-L-thyronine  (ISO)
3,3'-diindolylmethane  (EXP,ISO)
3,4-dichloroaniline  (ISO)
3,4-dihydroxybenzoic acid  (ISO)
3,4-Methylenedioxyamphetamine  (ISO)
3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione  (EXP,ISO)
3-acetyldeoxynivalenol  (ISO)
3-hydroxyphenylacetic acid  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (ISO)
3-methoxycatechol  (ISO)
3-methyl-3H-imidazo[4,5-f]quinolin-2-amine  (ISO)
3-methyladenine  (EXP,ISO)
3-methylcholanthrene  (ISO)
3-nitropropanoic acid  (EXP)
3-phenylprop-2-enal  (EXP,ISO)
3-phenylpropionic acid  (ISO)
4,4'-methylene-bis-(2-chloroaniline)  (ISO)
4,4'-sulfonyldiphenol  (EXP,ISO)
4-(ethoxymethylene)-2-phenyloxazol-5-one  (ISO)
4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one  (ISO)
4-chlorobiphenyl  (ISO)
4-ethoxyaniline  (ISO)
4-hydroxy-17beta-estradiol  (ISO)
4-hydroxy-TEMPO  (EXP)
4-hydroxyphenyl retinamide  (ISO)
4-nitroquinoline N-oxide  (EXP,ISO)
4-phenylbutyric acid  (ISO)
5,6,7-trimethoxyflavone  (ISO)
5-(2-methylpiperazine-1-sulfonyl)isoquinoline  (ISO)
5-(N,N-hexamethylene)amiloride  (ISO)
5-aza-2'-deoxycytidine  (ISO)
5-fluorouracil  (EXP,ISO)
5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole  (EXP,ISO)
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide  (ISO)
6-Methoxyflavone  (ISO)
6-oxoprostaglandin F1alpha  (ISO)
6-propyl-2-thiouracil  (EXP)
6alpha-methylprednisolone  (ISO)
7,12-dimethyltetraphene  (EXP,ISO)
7,8-diacetoxy-4-methylcoumarin  (ISO)
7-nitroindazole  (EXP)
7alpha-hydroxycholesterol  (ISO)
8-Br-cAMP  (ISO)
8-epi-prostaglandin F2alpha  (ISO)
8-hydroxy-2'-deoxyguanosine  (ISO)
8-OH-DPAT  (ISO)
9,10-anthraquinone  (ISO)
9-(tetrahydrofuryl)adenine  (ISO)
9-cis-retinoic acid  (ISO)
9-Methoxycamptothecin  (ISO)
[6]-Shogaol  (ISO)
AACOCF3  (ISO)
acadesine  (ISO)
acenaphthoquinone  (ISO)
acetaldehyde  (ISO)
acetic acid  (EXP,ISO)
acetylsalicylic acid  (EXP,ISO)
Aciculatin  (ISO)
acrolein  (ISO)
acrylamide  (EXP,ISO)
acteoside  (ISO)
actinomycin D  (EXP,ISO)
acyclovir  (ISO)
aflatoxin B1  (ISO)
Aflatoxin G1  (ISO)
afzelechin  (EXP)
AH23848  (ISO)
AICA ribonucleotide  (ISO)
albuterol  (ISO)
aldehydo-D-glucosamine  (EXP,ISO)
aldehydo-D-glucose  (EXP,ISO)
aldicarb  (EXP)
alendronic acid  (EXP)
alfacalcidol  (EXP)
aliskiren  (EXP)
all-trans-4-oxoretinoic acid  (ISO)
all-trans-retinoic acid  (EXP,ISO)
all-trans-retinol  (EXP)
allantoin  (EXP)
allopurinol  (EXP)
allyl alcohol  (EXP)
allyl methyl disulfide  (ISO)
Aloe emodin  (ISO)
alpha-Chaconine  (ISO)
alpha-D-galactose  (ISO)
alpha-linolenic acid  (EXP,ISO)
alpha-mangostin  (EXP)
alpha-methylhistamine  (ISO)
alpha-naphthoflavone  (ISO)
alpha-Spinasterol  (ISO)
alpha-Zearalanol  (ISO)
Alternaramide  (ISO)
alternariol  (ISO)
aluminium atom  (ISO)
aluminium hydroxide  (ISO)
aluminium sulfate (anhydrous)  (ISO)
aluminium(0)  (ISO)
amarogentin  (ISO)
amentoflavone  (ISO)
amikacin  (ISO)
amiloride  (EXP,ISO)
aminoguanidine  (EXP)
amiodarone  (ISO)
ammonium chloride  (EXP)
ammonium hexachloroplatinate  (ISO)
Ammothamnine  (ISO)
amodiaquine  (ISO)
amphetamine  (EXP)
amphibole asbestos  (EXP,ISO)
ampicillin  (EXP)
anandamide  (EXP,ISO)
Anemoside B4  (ISO)
anthocyanin  (ISO)
anthra[1,9-cd]pyrazol-6(2H)-one  (EXP,ISO)
anthracene-1,8,9-triol  (ISO)
antimony(0)  (ISO)
antimycin A  (ISO)
antirheumatic drug  (ISO)
apigenin  (EXP,ISO)
apocynin  (EXP,ISO)
arachidonic acid  (EXP,ISO)
Archazolid B  (ISO)
Arctiin  (ISO)
arecoline  (ISO)
aripiprazole  (ISO)
aristolochic acid A  (EXP)
arsane  (EXP,ISO)
arsenic atom  (EXP,ISO)
arsenite(3-)  (EXP,ISO)
arsenous acid  (EXP,ISO)
artesunate  (ISO)
asarone  (ISO)
asbestos  (ISO)
asiatic acid  (ISO)
astaxanthin  (EXP,ISO)
astilbin  (ISO)
atenolol  (ISO)
atorvastatin calcium  (EXP)
ATP  (ISO)
atrazine  (EXP,ISO)
atropine  (EXP)
auranofin  (ISO)
auraptene  (ISO)
aureusidin  (ISO)
azathioprine  (ISO)
Azoxymethane  (EXP,ISO)
baicalein  (ISO)
baicalin  (EXP)
bellidifolin  (ISO)
benfotiamine  (ISO)
benzalkonium chloride  (ISO)
benzamide  (EXP)
benzatropine  (ISO)
benzene  (ISO)
benzene-1,2,4-triol  (ISO)
benzidine  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[a]pyrene diol epoxide I  (EXP,ISO)
Benzo[a]pyrene-7,8-diol  (ISO)
benzo[b]fluoranthene  (ISO)
Benzo[k]fluoranthene  (ISO)
benzoic acid  (ISO)
Benzoyl peroxide  (ISO)
Benzoylpaeoniflorin  (ISO)
berberine  (ISO)
Bergenin  (EXP)
beryllium sulfate  (ISO)
Besigomsin  (ISO)
beta-amyrin  (ISO)
beta-D-glucosamine  (EXP,ISO)
beta-D-glucosamine 6-sulfate  (ISO)
beta-ionone  (ISO)
beta-naphthoflavone  (EXP)
beta-tocopherol  (EXP)
betulinic acid  (EXP)
bicalutamide  (ISO)
bifenthrin  (EXP,ISO)
biochanin A  (ISO)
biphenyl-2,2'-diol  (ISO)
biphenyl-2-ol  (ISO)
biphenyl-4,4'-diol  (ISO)
biphenyl-4-amine  (ISO)
bis(2-chloroethyl) sulfide  (EXP,ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisdemethoxycurcumin  (EXP,ISO)
bisphenol A  (EXP,ISO)
Bisphenol A diglycidyl ether  (ISO)
bisphenol A dimethacrylate  (ISO)
Bisphenol A glycidylmethacrylate  (ISO)
bisphenol AF  (EXP,ISO)
bisphenol F  (EXP,ISO)
bleomycin A2  (ISO)
Boldine  (EXP)
boric acid  (ISO)
bortezomib  (ISO)
Botulinum toxin type A  (EXP)
BQ 123  (EXP,ISO)
bromfenac  (ISO)
bromobenzene  (EXP)
brucine  (ISO)
bucladesine  (ISO)
budesonide  (EXP,ISO)
bufalin  (ISO)
bupivacaine  (ISO)
busulfan  (ISO)
butan-1-ol  (EXP,ISO)
butanal  (ISO)
butane-2,3-dione  (ISO)
Butralin  (EXP)
butylated hydroxyanisole  (ISO)
Butylbenzyl phthalate  (ISO)
butyric acid  (ISO)
C.I. Natural Red 20  (ISO)
cadmium acetate  (ISO)
cadmium atom  (EXP,ISO)
cadmium dichloride  (EXP,ISO)
cadmium sulfate  (EXP,ISO)
caffeine  (ISO)
Calcimycin  (ISO)
calciol  (EXP,ISO)
calcitriol  (EXP,ISO)
calcium atom  (EXP,ISO)
calcium(0)  (EXP,ISO)
camptothecin  (ISO)
candesartan  (ISO)
cannabidiol  (EXP,ISO)
cannabidiolic acid  (ISO)
capecitabine  (ISO)
capillarisin  (ISO)
capsaicin  (EXP,ISO)
capsazepine  (ISO)
captopril  (EXP,ISO)
carazolol  (ISO)
carbachol  (EXP)
carbon nanotube  (EXP,ISO)
carbonyl cyanide p-trifluoromethoxyphenylhydrazone  (ISO)
carboplatin  (ISO)
carfilzomib  (ISO)
carnosic acid  (ISO)
carnosine  (ISO)
carrageenan  (EXP,ISO)
carvacrol  (EXP,ISO)
carvedilol  (EXP)
Cassiastearoptene  (EXP)
casticin  (EXP)
catalpol  (ISO)
CCCP  (ISO)
celastrol  (ISO)
celecoxib  (EXP,ISO)
cerium trichloride  (ISO)
ceruletide  (EXP)
cetylpyridinium  (ISO)
chaetoglobosin A  (ISO)
chenodeoxycholic acid  (ISO)
chloramphenicol  (ISO)
chlordecone  (ISO)
chlorobenzene  (ISO)
chlorogenic acid  (EXP,ISO)
chloropicrin  (ISO)
chloroquine  (ISO)
chlorothalonil  (ISO)
chlorphenamine  (ISO)
chlorpropham  (ISO)
chlorpyrifos  (EXP,ISO)
choline  (EXP,ISO)
chondroitin sulfate  (ISO)
chromium(6+)  (ISO)
chrysin  (EXP,ISO)
chrysin 5,7-dimethyl ether  (EXP)
ciglitazone  (EXP,ISO)
cilostazol  (ISO)
cinaciguat  (EXP)
ciprofibrate  (ISO)
cirsilineol  (ISO)
Cirsimarin  (ISO)
cis-caffeic acid  (ISO)
cisplatin  (EXP,ISO)
citronellol  (EXP,ISO)
clofibrate  (EXP,ISO)
cobalt atom  (ISO)
cobalt dichloride  (EXP,ISO)
coenzyme Q10  (EXP)
colforsin daropate hydrochloride  (EXP,ISO)
conjugated linoleic acid  (ISO)
copper atom  (EXP,ISO)
copper(0)  (EXP,ISO)
copper(II) chloride  (ISO)
copper(II) sulfate  (EXP)
cordycepin  (ISO)
corilagin  (ISO)
corn oil  (ISO)
corosolic acid  (ISO)
corticosterone  (EXP)
cortisol  (EXP,ISO)
costunolide  (ISO)
crocidolite asbestos  (ISO)
crocin-1  (EXP,ISO)
cumene hydroperoxide  (ISO)
Cuprizon  (EXP)
curcumin  (EXP,ISO)
cycloheximide  (EXP,ISO)
cyclophosphamide  (EXP,ISO)
cyclosporin A  (EXP,ISO)
cyfluthrin  (ISO)
cyhalothrin  (EXP)
cypermethrin  (ISO)
cyprodinil  (ISO)
cytarabine  (ISO)
D-glucose  (EXP,ISO)
D-penicillamine  (ISO)
daidzein  (ISO)
dapagliflozin  (EXP)
dapoxetine  (EXP)
DAPT  (EXP,ISO)
daunorubicin  (EXP)
DDD  (ISO)
DDE  (ISO)
DDT  (ISO)
Decursin  (ISO)
deguelin  (ISO)
dehydrocostus lactone  (ISO)
Dehydrodiisoeugenol  (ISO)
delphinidin  (ISO)
delta-tocopherol  (EXP)
demethoxycurcumin  (ISO)
deoxycholic acid  (ISO)
deoxynivalenol  (ISO)
desferrioxamine B  (EXP,ISO)
dexamethasone  (EXP,ISO)
dextran sulfate  (EXP,ISO)
dextromethorphan  (ISO)
Diacetoxyscirpenol  (ISO)
diallyl disulfide  (ISO)
Diallyl sulfide  (ISO)
diallyl trisulfide  (ISO)
diarsenic trioxide  (EXP,ISO)
diazinon  (ISO)
dibenziodolium  (ISO)
dibenzofuran  (EXP)
dibenzoylmethane  (ISO)
Dibutyl phosphate  (ISO)
dibutyl phthalate  (ISO)
dichlorine  (ISO)
dichloromethane  (ISO)
diclofenac  (EXP,ISO)
dieckol  (ISO)
dienogest  (ISO)
diethyl phthalate  (ISO)
Dihydrotanshinone I  (ISO)
diisobutyl phthalate  (ISO)
diisononyl phthalate  (ISO)
diisopropyl fluorophosphate  (EXP)
dimethoate  (EXP)
dimethyl sulfoxide  (EXP,ISO)
dimethylarsinic acid  (EXP)
dimethylarsinous acid  (ISO)
dioscin  (EXP)
diosgenin  (ISO)
diosmin  (EXP,ISO)
dioxygen  (EXP,ISO)
diphenhydramine  (ISO)
dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate  (ISO)
dipyridamole  (EXP,ISO)
diquat  (EXP)
disodium selenite  (EXP,ISO)
disulfiram  (EXP)
diuron  (ISO)
dizocilpine maleate  (ISO)
dobutamine  (ISO)
donepezil hydrochloride  (ISO)
dorsomorphin  (ISO)
doxorubicin  (EXP,ISO)
DuP 697  (EXP,ISO)
edelfosine  (ISO)
EGTA acetoxymethyl ester  (ISO)
elemental selenium  (EXP,ISO)
embelin  (ISO)
emodin  (EXP,ISO)
enalapril  (EXP,ISO)
endosulfan  (EXP,ISO)
enilconazole  (ISO)
enniatin  (ISO)
entacapone  (ISO)
entinostat  (ISO)
equol  (ISO)
erastin  (EXP,ISO)
ergosta-4,6,8(14),22-tetraen-3-one  (ISO)
eriodictyol  (ISO)
eritoran  (ISO)
erlotinib hydrochloride  (ISO)
esmolol  (ISO)
ethanol  (EXP,ISO)
Ethyl pyruvate  (EXP,ISO)
ethylbenzene  (ISO)
ethylisopropylamiloride  (ISO)
etodolac  (EXP,ISO)
etoposide  (ISO)
etoricoxib  (EXP,ISO)
eugenol  (EXP,ISO)
eupatilin  (ISO)
everolimus  (EXP)
Evodiamine  (ISO)
famotidine  (EXP,ISO)
febuxostat  (EXP)
fenbendazole  (ISO)
fenhexamid  (ISO)
fenofibrate  (ISO)
ferric ammonium citrate  (ISO)
ferrosoferric oxide  (ISO)
ferrostatin-1  (EXP,ISO)
ferulic acid  (EXP,ISO)
Fexofenadine hydrochloride  (ISO)
finasteride  (EXP)
fisetin  (EXP)
Flavokawain A  (ISO)
flavone  (ISO)
fludioxonil  (ISO)
fludrocortisone  (ISO)
flufenamic acid  (ISO)
fluoranthene  (ISO)
fluoxetine  (EXP)
flupenthixol  (ISO)
flurbiprofen  (EXP,ISO)
Fluridone  (ISO)
flutamide  (ISO)
fluvoxamine  (EXP,ISO)
folic acid  (ISO)
formaldehyde  (EXP,ISO)
formononetin  (ISO)
Forsythiaside  (ISO)
Fraxinellone  (ISO)
fructose  (EXP)
fucoidan  (ISO)
fucoxanthin  (ISO)
fulvestrant  (ISO)
Fulvic acid  (ISO)
furfural  (ISO)
furosemide  (EXP)
Fusarenone X  (ISO)
galactose  (ISO)
gallic acid  (EXP,ISO)
gamma-hexachlorocyclohexane  (EXP)
gamma-linolenic acid  (ISO)
gamma-tocopherol  (EXP,ISO)
gardenoside  (EXP)
gardiquimod  (ISO)
Gastrodin  (ISO)
gefitinib  (ISO)
geldanamycin  (EXP)
gemcitabine  (ISO)
genistein  (EXP,ISO)
genistein 7-O-beta-D-glucoside  (ISO)
genkwanin  (ISO)
gentamycin  (EXP)
geraniol  (EXP,ISO)
gingerol  (ISO)
ginsenoside C-K  (EXP,ISO)
ginsenoside Re  (ISO)
ginsenoside Rg1  (ISO)
glucaric acid  (ISO)
glucose  (EXP,ISO)
glutathione  (EXP,ISO)
glyburide  (EXP)
glycidol  (EXP)
glycine betaine  (EXP)
glycochenodeoxycholic acid  (ISO)
glycocholic acid  (ISO)
glycodeoxycholic acid  (ISO)
glycyrol  (ISO)
glycyrrhetinate  (ISO)
glycyrrhetinic acid  (ISO)
glycyrrhizinic acid  (ISO)
glyphosate  (EXP,ISO)
Goe 6976  (EXP,ISO)
gold atom  (ISO)
gold(0)  (ISO)
gossypin  (EXP)
guaiacol  (ISO)
guggulsterone  (ISO)
GW 1929  (ISO)
GW 501516  (ISO)
haloperidol  (ISO)
halothane  (EXP)
harmaline  (ISO)
Harpagoside  (ISO)
helenalin  (ISO)
helioxanthin  (ISO)
heparin  (EXP)
herbacetin  (EXP)
herbimycin  (EXP)
hesperetin  (EXP,ISO)
hesperidin  (EXP,ISO)
hexachlorobenzene  (ISO)
hexane  (ISO)
hinokiflavone  (ISO)
histamine  (EXP,ISO)
homocysteine  (ISO)
homoeriodictyol  (ISO)
Honokiol  (ISO)
hydrochlorothiazide  (EXP)
hydrogen chloride  (EXP,ISO)
hydrogen peroxide  (EXP,ISO)
hydrogen sulfide  (ISO)
hydroquinone  (ISO)
hydroxytyrosol  (ISO)
Ibudilast  (EXP)
ibuprofen  (EXP,ISO)
icariin  (ISO)
icariside II  (ISO)
icatibant  (EXP)
ICI 118551  (ISO)
icosanoid  (ISO)
ifosfamide  (EXP)
iloprost  (ISO)
imidacloprid  (EXP)
imidazoles  (ISO)
immunological adjuvant  (EXP)
indirubin-3'-monoxime  (ISO)
indole-3-methanol  (ISO)
indometacin  (EXP,ISO)
indoprofen  (ISO)
indoxyl sulfate  (EXP,ISO)
Inotodiol  (ISO)
irbesartan  (EXP)
irinotecan  (ISO)
iron atom  (EXP,ISO)
iron dextran  (EXP)
iron(0)  (EXP,ISO)
iron(2+) sulfate (anhydrous)  (EXP)
iron(III) citrate  (ISO)
iron(III) nitrilotriacetate  (EXP)
isatin  (EXP)
isoflurane  (EXP)
isoliquiritigenin  (EXP,ISO)
isoniazide  (ISO)
isoprenaline  (EXP,ISO)
isorhamnetin  (EXP,ISO)
isothiocyanate  (ISO)
isotretinoin  (ISO)
ivermectin  (ISO)
JTE-013  (ISO)
juglone  (ISO)
kaempferol  (ISO)
kaempferol 3-O-beta-D-glucoside  (ISO)
kainic acid  (EXP,ISO)
kenpaullone  (EXP)
ketoconazole  (ISO)
ketoprofen  (ISO)
ketorolac  (EXP,ISO)
ketorolac tromethamine  (ISO)
KN-93  (ISO)
KT 5720  (ISO)
L-1,4-dithiothreitol  (ISO)
L-arginine  (EXP)
L-ascorbic acid  (EXP,ISO)
L-dehydroascorbic acid  (EXP)
L-gamma-glutamyl-L-cysteine  (ISO)
L-glutamic acid  (ISO)
L-methionine  (ISO)
L-proline betaine  (ISO)
lactucin  (ISO)
lansoprazole  (EXP)
lapatinib  (ISO)
Lasiocarpine  (ISO)
lead diacetate  (EXP,ISO)
lead nitrate  (ISO)
lead(0)  (EXP,ISO)
Leonurine  (EXP)
levamisole  (ISO)
levofloxacin  (ISO)
Licarin A  (EXP)
lidocaine  (EXP)
linderalactone  (ISO)
linoleic acid  (EXP,ISO)
linuron  (ISO)
lipoic acid  (EXP)
lipopolysaccharide  (EXP,ISO)
lipoteichoic acid  (EXP,ISO)
lipoxin A4  (EXP)
liraglutide  (EXP)
lithium chloride  (EXP,ISO)
lithocholic acid  (ISO)
loganin  (ISO)
lonafarnib  (ISO)
lornoxicam  (ISO)
losartan  (EXP,ISO)
lovastatin  (EXP,ISO)
Lucidone  (ISO)
lumiracoxib  (ISO)
lupeol  (EXP)
lutein  (ISO)
luteolin  (EXP,ISO)
Luteolin 7-methyl ether  (ISO)
LY294002  (EXP,ISO)
lycopene  (ISO)
lycorine  (ISO)
lysophosphatidylcholine  (EXP)
Malabaricone C  (ISO)
malaoxon  (ISO)
malathion  (ISO)
maleimides  (ISO)
mancozeb  (ISO)
manganese atom  (EXP,ISO)
manganese(0)  (EXP,ISO)
manganese(II) chloride  (EXP,ISO)
mangiferin  (EXP,ISO)
manoalide  (ISO)
maslinic acid  (ISO)
masoprocol  (ISO)
MC1568  (ISO)
mebendazole  (ISO)
mechlorethamine  (EXP,ISO)
medroxyprogesterone acetate  (ISO)
MeIQx  (ISO)
melatonin  (ISO)
melittin  (ISO)
meloxicam  (EXP,ISO)
melphalan  (ISO)
mercury dichloride  (EXP)
mesalamine  (EXP,ISO)
metaproterenol  (ISO)
metformin  (EXP,ISO)
methamphetamine  (EXP,ISO)
Methanandamide  (ISO)
methanol  (ISO)
methiocarb  (ISO)
methomyl  (EXP)
methotrexate  (EXP,ISO)
methoxamine  (EXP)
methylisothiazolinone  (ISO)
methylmercury chloride  (ISO)
methyltestosterone  (ISO)
metoprolol  (EXP,ISO)
mevalonic acid  (ISO)
microcystin-LR  (ISO)
midostaurin  (EXP)
mifepristone  (EXP)
minocycline  (ISO)
miquelianin  (ISO)
misoprostol  (EXP)
mitomycin C  (ISO)
Mitotane  (ISO)
MitoTEMPO  (EXP,ISO)
Mitragynine  (ISO)
MK-2206  (ISO)
Mofezolac (TN)  (EXP)
monascin  (ISO)
mono(2-ethylhexyl) phthalate  (EXP,ISO)
monobenzyl phthalate  (ISO)
Monobutylphthalate  (ISO)
monotropein  (ISO)
montelukast  (ISO)
morin  (EXP)
morphine  (EXP,ISO)
Morroniside  (ISO)
morusin  (ISO)
myo-inositol hexakisphosphate  (ISO)
myricetin  (ISO)
myricitrin  (ISO)
N(gamma)-nitro-L-arginine methyl ester  (EXP,ISO)
N(omega)-methyl-L-arginine  (ISO)
N,N-dimethylformamide  (ISO)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (ISO)
N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide  (ISO)
N-acetyl-L-cysteine  (EXP,ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (EXP,ISO)
N-butyl-N-(4-hydroxybutyl)nitrosamine  (EXP)
N-ethyl-N-nitrosourea  (ISO)
N-feruloyltyramine  (ISO)
N-formyl-L-methionyl-L-leucyl-L-phenylalanine  (ISO)
N-methyl-4-phenylpyridinium  (EXP,ISO)
N-methyl-N-nitrosourea  (EXP)
N-nitrosodiethylamine  (EXP,ISO)
N-phosphocreatine  (EXP)
N-tosyl-L-phenylalanyl chloromethyl ketone  (ISO)
N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine  (EXP)
nabumetone  (EXP)
naphthalenes  (EXP,ISO)
naproxen  (EXP,ISO)
Narciclasine  (ISO)
naringin  (EXP,ISO)
NCX-4040  (ISO)
nebivolol  (ISO)
nectandrin B  (ISO)
Neferine  (EXP)
neoastilbin  (ISO)
neoechinulin A  (ISO)
neohesperidin  (ISO)
neohesperidin dihydrochalcone  (ISO)
nerolidol  (EXP)
nickel atom  (ISO)
nickel dichloride  (ISO)
nickel subsulfide  (EXP)
nickel sulfate  (ISO)
nicorandil  (EXP)
nicotinamide  (ISO)
nicotine  (EXP,ISO)
nicotinic acid  (ISO)
nifedipine  (EXP,ISO)
Niflumic acid  (ISO)
nimesulide  (EXP,ISO)
nitric oxide  (EXP)
nitrofen  (EXP)
nitrogen dioxide  (ISO)
nitroprusside  (ISO)
nobiletin  (EXP)
nomifensine  (ISO)
Nonylphenol  (EXP,ISO)
Nookatone  (EXP)
notoginsenoside R1  (ISO)
NS-398  (EXP,ISO)
o-anisidine  (ISO)
o-cresol  (EXP)
O-methylsalicylic acid  (ISO)
Obacunone  (ISO)
ochratoxin A  (ISO)
ofloxacin  (EXP)
okadaic acid  (ISO)
oleanolic acid  (ISO)
oleic acid  (ISO)
oleoyl ethanolamide  (ISO)
oleuropein  (EXP,ISO)
omeprazole  (EXP,ISO)
omethoate  (EXP)
onapristone  (EXP)
orciprenaline  (ISO)
organoselenium compound  (EXP,ISO)
oridonin  (EXP)
orlistat  (ISO)
oroxylin A  (ISO)
osimertinib  (EXP)
ouabain  (EXP)
oxaliplatin  (EXP,ISO)
oxidopamine  (EXP,ISO)
oxybenzone  (ISO)
oxytocin  (EXP,ISO)
ozone  (EXP,ISO)
p-tolualdehyde  (ISO)
Pachymic acid  (ISO)
paclitaxel  (ISO)
paeoniflorin  (ISO)
Paeonol  (ISO)
paracetamol  (EXP,ISO)
paraquat  (EXP,ISO)
paricalcitol  (ISO)
paroxetine  (ISO)
parthenolide  (EXP,ISO)
patchouli alcohol  (EXP)
PCB138  (ISO)
pelargonidin  (ISO)
penbutolol  (ISO)
pentane-2,3-dione  (ISO)
Pentoxifylline  (EXP)
peptidoglycan  (ISO)
perfluorooctane-1-sulfonic acid  (ISO)
perfluorooctanoic acid  (ISO)
permethrin  (EXP)
Pf-06840003  (ISO)
PGI3  (ISO)
phenanthridone  (EXP)
phenethyl caffeate  (EXP)
phenethyl isothiocyanate  (ISO)
phenobarbital  (EXP)
phenylarsine oxide  (EXP,ISO)
phenylbutazone  (ISO)
phenylephrine  (EXP)
phenylhydrazine  (ISO)
phenytoin  (EXP)
PhIP  (ISO)
phloretic acid  (ISO)
phorbol 13-acetate 12-myristate  (EXP,ISO)
phosgene  (EXP,ISO)
phosphatidic acid  (ISO)
phosphorus atom  (ISO)
phosphorus(.)  (ISO)
pifithrin-alpha hydrobromide  (EXP)
pinostrobin  (EXP)
pioglitazone  (EXP,ISO)
piperine  (ISO)
pipoxolan  (ISO)
pirimiphos-methyl  (ISO)
pirinixic acid  (ISO)
piroxicam  (EXP,ISO)
platinum  (ISO)
platinum(0)  (ISO)
platycodin D  (EXP,ISO)
pluronic P-123  (ISO)
Poloxamer  (ISO)
poly(I:C)  (ISO)
poly(vinylpyrrolidone)  (EXP)
polymyxin B2  (ISO)
ponasterone A  (EXP)
potassium bromate  (ISO)
potassium chloride  (EXP)
potassium iodide  (ISO)
Pranoprofen  (ISO)
pravastatin  (EXP)
prednisolone  (ISO)
PRIM-O-GLUCOSYLCIMIFUGIN  (ISO)
pristane  (ISO)
proanthocyanidin  (EXP)
probenecid  (EXP)
procyclidine  (ISO)
prodigiosin  (EXP)
progesterone  (EXP,ISO)
propiconazole  (EXP)
propranolol  (ISO)
prostaglandin A1  (ISO)
prostaglandin D2  (ISO)
prostaglandin D3  (ISO)
prostaglandin E2  (EXP,ISO)
prostaglandin E3  (ISO)
prostaglandin F1alpha  (ISO)
prostaglandin F2alpha  (EXP,ISO)
prostaglandin G2  (ISO)
prostaglandin I2  (EXP)
protein kinase inhibitor  (ISO)
protoporphyrin  (ISO)
protosappanin A  (EXP,ISO)
protriptyline  (ISO)
prunetin  (ISO)
pterostilbene  (ISO)
puerarin  (EXP,ISO)
puromycin  (ISO)
pyrazines  (ISO)
pyrene  (ISO)
pyridoxamine  (ISO)
pyrimethanil  (ISO)
pyrogallol  (EXP)
pyrrolidine dithiocarbamate  (EXP,ISO)
quartz  (EXP,ISO)
quercetin  (EXP,ISO)
quercetin 3-O-beta-D-glucofuranoside  (EXP)
quercetin 3-O-beta-D-glucopyranoside  (EXP)
quercetin 3-sulfate  (ISO)
rac-lactic acid  (ISO)
radon atom  (ISO)
radon(0)  (ISO)
raloxifene  (EXP,ISO)
ramipril  (EXP)
ranitidine  (EXP)
reactive oxygen species  (EXP,ISO)
Rebamipide  (EXP)
rebaudioside A  (ISO)
reserpine  (EXP)
resolvin D1  (ISO)
resolvin D2  (ISO)
resorcinol  (ISO)
resveratrol  (EXP,ISO)
Rhein  (ISO)
ricinine  (ISO)
rimonabant  (ISO)
rivastigmine  (ISO)
Ro 31-8220  (ISO)
robinin  (EXP)
rofecoxib  (EXP,ISO)
rotenone  (EXP,ISO)
rottlerin  (ISO)
rubimaillin  (ISO)
Rutecarpine  (ISO)
rutin  (EXP,ISO)
S-(1,2-dichlorovinyl)-L-cysteine  (ISO)
S-adenosyl-L-methioninate  (ISO)
S-adenosyl-L-methionine  (ISO)
S-allylcysteine  (ISO)
S-butyl-DL-homocysteine (S,R)-sulfoximine  (ISO)
Salvianolic acid A  (ISO)
sarpogrelate  (EXP)
SB 203580  (EXP,ISO)
SB 431542  (ISO)
SC-58125  (EXP,ISO)
SC-791  (ISO)
scalaradial  (ISO)
scopolamine  (ISO)
selenium atom  (EXP,ISO)
senecionine  (ISO)
Senkirkine  (ISO)
serotonin  (EXP,ISO)
serpentine asbestos  (ISO)
sertraline  (ISO)
Sesamol  (ISO)
sevoflurane  (EXP)
Shikonin  (ISO)
silibinin  (ISO)
silicon atom  (EXP)
silicon dioxide  (EXP,ISO)
silver atom  (EXP,ISO)
silver(0)  (EXP,ISO)
simvastatin  (EXP,ISO)
sinapic acid  (EXP,ISO)
sirolimus  (EXP,ISO)
sirtinol  (ISO)
SKF-96365 hydrochloride  (ISO)
sodium arsenate  (ISO)
sodium arsenite  (EXP,ISO)
sodium atom  (EXP)
sodium aurothiomalate  (ISO)
sodium benzoate  (ISO)
sodium chloride  (EXP,ISO)
sodium chromate  (ISO)
sodium dodecyl sulfate  (ISO)
sodium fluoride  (EXP,ISO)
sodium hydrogensulfite  (EXP,ISO)
Sodium salicylate  (ISO)
sodium sulfite  (EXP)
Soman  (EXP)
Sophocarpine  (ISO)
Sophoricoside  (ISO)
sorbinil  (ISO)
soyasaponin I  (ISO)
sphinganine 1-phosphate  (ISO)
sphingosine 1-phosphate  (ISO)
staurosporine  (ISO)
stavudine  (ISO)
sterigmatocystin  (EXP)
steviol  (ISO)
stevioside  (ISO)
stigmasterol  (ISO)
streptozocin  (EXP,ISO)
styrene  (ISO)
succimer  (ISO)
succinic acid  (ISO)
sucrose  (EXP)
sulfasalazine  (EXP,ISO)
sulforaphane  (EXP,ISO)
sulfur dioxide  (EXP,ISO)
sulindac  (EXP,ISO)
sulindac sulfide  (ISO)
sulindac sulfone  (EXP,ISO)
Sunset Yellow FCF  (EXP)
superoxide  (ISO)
suramin  (ISO)
Swertiamarin  (EXP)
syringic acid  (EXP)
T-2 toxin  (ISO)
tacrine  (EXP,ISO)
tacrolimus hydrate  (ISO)
taiwanin C  (ISO)
tamarixetin  (ISO)
tamoxifen  (ISO)
tangeretin  (EXP)
tannic acid  (EXP)
Tanshinone I  (ISO)
tartrazine  (ISO)
taurocholic acid  (ISO)
taurodeoxycholic acid  (EXP)
tebuconazole  (ISO)
telmisartan  (EXP,ISO)
temozolomide  (ISO)
TEMPO  (ISO)
tenofovir disoproxil fumarate  (EXP)
tephrosin  (ISO)
terameprocol  (ISO)
terephthalic acid  (EXP)
tert-butyl hydroperoxide  (EXP,ISO)
testosterone  (EXP)
Testosterone propionate  (EXP)
tetrachloro-1,4-benzoquinone  (ISO)
tetrachloromethane  (EXP,ISO)
tetracycline  (ISO)
tetradecane  (EXP)
tetrahydrocurcumin  (ISO)
tetrahydropalmatine  (ISO)
tetramethylpyrazine  (ISO)
tetraphene  (ISO)
tetrathiomolybdate(2-)  (ISO)
thalidomide  (EXP,ISO)
thapsigargin  (ISO)
theaflavin  (ISO)
Theaflavin 3,3'-digallate  (EXP)
thenoyltrifluoroacetone  (ISO)
thiamet G  (ISO)
thiamethoxam  (ISO)
thiamine(1+) chloride  (EXP)
thioacetamide  (EXP,ISO)
thiocitrulline  (EXP)
thiophanate-methyl  (EXP)
thiourea  (ISO)
thiram  (ISO)
thromboxane A2  (ISO)
thromboxane B2  (ISO)
thymol  (EXP)
thymol sulfate(1-)  (EXP)
thyroxine  (EXP,ISO)
tienilic acid  (ISO)
titanium dioxide  (EXP,ISO)
tolcapone  (ISO)
tolterodine tartrate  (ISO)
toluene  (ISO)
topotecan  (EXP)
Torularhodin  (ISO)
trans-caffeic acid  (ISO)
trans-piceid  (ISO)
trazodone  (EXP,ISO)
Tremulacin  (ISO)
tributylstannane  (EXP,ISO)
trichloroethene  (EXP,ISO)
trichostatin A  (ISO)
triclosan  (ISO)
Trihexyphenidyl  (ISO)
triphenyl phosphate  (ISO)
Triptolide  (EXP,ISO)
triptonide  (ISO)
troglitazone  (EXP,ISO)
tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate  (EXP)
trovafloxacin  (ISO)
Tungsten carbide  (ISO)
tunicamycin  (EXP,ISO)
Tylophorine  (ISO)
tyrphostin AG 1478  (EXP,ISO)
U-73122  (ISO)
undecane  (EXP)
uranium atom  (EXP)
urethane  (EXP,ISO)
ursodeoxycholic acid  (EXP,ISO)
ursolic acid  (ISO)
valdecoxib  (ISO)
valproic acid  (EXP,ISO)
valsartan  (EXP,ISO)
vanadium atom  (ISO)
vanadium(0)  (ISO)
vanadyl sulfate  (ISO)
vanillin  (ISO)
vemurafenib  (ISO)
venom  (ISO)
vincristine  (ISO)
vinorelbine  (ISO)
vinyl carbamate  (ISO)
vitamin E  (EXP,ISO)
vorinostat  (EXP,ISO)
VX nerve agent  (EXP)
wedelolactone  (ISO)
withaferin A  (ISO)
wogonin  (ISO)
wortmannin  (ISO)
xanthohumol  (EXP,ISO)
yohimbine  (EXP)
zafirlukast  (ISO)
zearalenone  (ISO)
zerumbone  (ISO)
zidovudine  (ISO)
zileuton  (ISO)
zinc atom  (EXP,ISO)
zinc oxide  (ISO)
zinc protoporphyrin  (EXP,ISO)
zinc(0)  (EXP,ISO)
zingerone  (EXP)
zoledronic acid  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
angiogenesis  (IMP)
bone mineralization  (IMP)
brown fat cell differentiation  (ISO)
cellular oxidant detoxification  (IEA)
cellular response to ATP  (IEP)
cellular response to fluid shear stress  (ISO)
cellular response to heat  (IEP)
cellular response to homocysteine  (IEP)
cellular response to hypoxia  (ISO)
cellular response to lead ion  (IEP)
cellular response to lipopolysaccharide  (IEP)
cellular response to mechanical stimulus  (IEP)
cellular response to non-ionic osmotic stress  (ISO)
cyclooxygenase pathway  (IBA,ISO,ISS)
decidualization  (IMP,ISO)
embryo implantation  (IMP,ISO)
fatty acid biosynthetic process  (IEA)
fatty acid metabolic process  (IEA)
hair cycle  (IEP)
learning  (IEA,IMP)
lipid metabolic process  (IEA)
maintenance of blood-brain barrier  (IEA,IMP)
memory  (IEA,IMP)
negative regulation of apoptotic process  (ISO)
negative regulation of calcium ion transport  (IMP)
negative regulation of cell cycle  (IGI)
negative regulation of cell population proliferation  (IDA)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress  (ISO)
negative regulation of smooth muscle contraction  (IMP)
negative regulation of synaptic transmission, dopaminergic  (IMP)
positive regulation of apoptotic process  (IMP)
positive regulation of brown fat cell differentiation  (ISO)
positive regulation of cell migration involved in sprouting angiogenesis  (IMP)
positive regulation of cell population proliferation  (IMP)
positive regulation of fever generation  (IDA,ISO)
positive regulation of fibroblast growth factor production  (IMP)
positive regulation of nitric oxide biosynthetic process  (IMP)
positive regulation of platelet-derived growth factor production  (IMP)
positive regulation of prostaglandin biosynthetic process  (ISO)
positive regulation of protein import into nucleus  (IMP)
positive regulation of smooth muscle cell proliferation  (IMP)
positive regulation of smooth muscle contraction  (IEA,IMP)
positive regulation of synaptic plasticity  (IMP)
positive regulation of synaptic transmission, glutamatergic  (IMP)
positive regulation of transforming growth factor beta production  (IMP)
positive regulation of vascular endothelial growth factor production  (IMP)
positive regulation of vasoconstriction  (IEA,IMP)
prostaglandin biosynthetic process  (IEA,IMP,ISO)
prostaglandin metabolic process  (IEA)
prostaglandin secretion  (ISO)
prostanoid biosynthetic process  (ISO)
regulation of blood pressure  (ISO,ISS)
regulation of cell population proliferation  (ISO)
regulation of neuroinflammatory response  (ISO,ISS)
response to angiotensin  (IEP)
response to cytokine  (IMP)
response to estradiol  (IEP)
response to fatty acid  (IEA,IEP)
response to fructose  (IEP)
response to glucocorticoid  (IEP)
response to lipopolysaccharide  (IMP)
response to manganese ion  (IEP)
response to nematode  (ISO)
response to oxidative stress  (IEA)
response to selenium ion  (ISO)
response to tumor necrosis factor  (IEP)
response to vitamin D  (IEP)
response to xenobiotic stimulus  (IEP)

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
acetylsalicylic acid pharmacodynamics pathway  (ISO)
antipyrine drug pathway  (ISO)
arachidonic acid metabolic pathway  (IEA,ISO)
celecoxib pharmacodynamics pathway  (ISO)
celecoxib pharmacokinetics pathway   (ISO)
cyclooxygenase mediated pathway of arachidonic acid metabolism  (ISO)
diclofenac pharmacodynamics pathway  (ISO)
diflunisal pharmacodynamics pathway  (ISO)
etodolac pharmacodynamics pathway  (ISO)
etoposide pharmacodynamics pathway  (ISO)
etoposide pharmacokinetics pathway  (ISO)
fenoprofen pharmacodynamics pathway  (ISO)
flurbiprofen pharmacodynamics pathway  (ISO)
ibuprofen pharmacodynamics pathway  (ISO)
ibuprofen pharmacokinetics pathway  (ISO)
indometacin pharmacodynamics pathway  (ISO)
indometacin pharmacodynamics pathway  (ISO)
ketoprofen pharmacodynamics pathway  (ISO)
ketorolac pharmacodynamics pathway  (ISO)
Leishmaniasis pathway  (IEA)
leukotriene C4 synthase deficiency pathway  (ISO)
lornoxicam pharmacodynamics pathway  (ISO)
lung small cell carcinoma pathway  (IEA)
magnesium salicylate pharmacodynamics pathway  (ISO)
mefenamic acid pharmacodynamics pathway  (ISO)
meloxicam pharmacodynamics pathway  (ISO)
nabumetone pharmacodynamics pathway  (ISO)
naproxen pharmacodynamics pathway   (ISO)
paracetamol drug pathway  (ISO)
piroxicam pharmacodynamics pathway  (ISO)
pro-inflammatory cytokine mediated pathway   (IDA)
prostanoid biosynthetic pathway  (ISO)
salicylic acid pharmacodynamics pathway  (ISO)
sodium salicylate pharmacodynamics pathway  (ISO)
sphingosine 1-phosphate signaling pathway  (ISO)
sulindac pharmacodynamics pathway  (ISO)
tenoxicam pharmacodynamics pathway  (ISO)
tiaprofenic acid pharmacodynamics pathway  (ISO)
tolmetin pharmacodynamics pathway  (ISO)
valdecoxib pharmacodynamics pathway   (ISO)
vascular endothelial growth factor signaling pathway  (IEA)

References

References - curated
# Reference Title Reference Citation
1. Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses. Alvarez Y, etal., J Hypertens. 2005 Apr;23(4):767-77.
2. Celecoxib as an in vivo probe of cyclooxygenase-2 mechanisms underlying retrograde amnesia in an animal model of ECT. Andrade C, etal., J Neural Transm. 2008 Jul;115(7):1063-70. Epub 2008 Jun 4.
3. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog. Aparna R, etal., J Cell Biochem. 2008 Aug 1;104(5):1832-42.
4. The prognostic significance of COX-2 and survivin expression in ovarian cancer. Athanassiadou P, etal., Pathol Res Pract. 2008;204(4):241-9. Epub 2008 Jan 2.
5. The neuroprotective effects of cyclooxygenase-2 inhibition in a mouse model of aneurysmal subarachnoid hemorrhage. Ayer R, etal., Acta Neurochir Suppl. 2011;111:145-9.
6. Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE). Ayoub SS, etal., Inflamm Res. 2011 Oct;60(10):919-28. Epub 2011 Jun 12.
7. Loss of 15-hydroxyprostaglandin dehydrogenase indicates a tumor suppressor role in pituitary adenomas. Bai JW, etal., Oncol Rep. 2012 Aug;28(2):714-20. doi: 10.3892/or.2012.1806. Epub 2012 May 9.
8. Overexpression of ELAV-like Protein HuR is Associated with Increased COX-2 Expression in Atrophy, High-grade Prostatic Intraepithelial Neoplasia, and Incidental Prostate Cancer in Cystoprostatectomies. Barbisan F, etal., Eur Urol. 2008 Apr 30.
9. Uteroplacental insufficiency alters nephrogenesis and downregulates cyclooxygenase-2 expression in a model of IUGR with adult-onset hypertension. Baserga M, etal., Am J Physiol Regul Integr Comp Physiol. 2007 May;292(5):R1943-55. Epub 2007 Feb 1.
10. Serum Concentrations of Cyclooxygenase-2 in Patients with Systemic Sclerosis: Association with Lower Frequency of Pulmonary Fibrosis. Bassyouni IH, etal., J Clin Immunol. 2011 Oct 7.
11. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Benish M, etal., Ann Surg Oncol. 2008 Jul;15(7):2042-52. Epub 2008 Apr 9.
12. Inhibition of cyclooxygenase-2 aggravates secretory phospholipase A2-mediated progression of acute liver injury. Bhave VS, etal., Toxicol Appl Pharmacol. 2008 Apr 15;228(2):239-46. Epub 2008 Jan 4.
13. COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia. Birkenmeier K, etal., Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2148-54. Epub 2007 Jul 27.
14. In altering the release of glucocorticoids, ketorolac exacerbates the effects of systemic immune stimuli on expression of proinflammatory genes in the brain. Blais V, etal., Endocrinology 2002 Dec;143(12):4820-7.
15. [Prognostic significance of cyclooxygenase (COX-1 and COX-2) expression in endometrial carcinoma (clinical and immunohistochemical study)] Boldarian NA, etal., Vopr Onkol. 2008;54(1):40-6.
16. Reduced expression of cyclooxygenase-2 in primary breast cancer. Boneberg EM, etal., J Natl Cancer Inst. 2008 Jul 16;100(14):1042-3. Epub 2008 Jul 8.
17. Genes that mediate breast cancer metastasis to the brain. Bos PD, etal., Nature. 2009 Jun 18;459(7249):1005-9. Epub 2009 May 6.
18. Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain. Bosetti F, etal., Mol Psychiatry. 2002;7(8):845-50.
19. Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. Brambilla R, etal., J Neurochem 2002 Dec;83(6):1285-96.
20. PGE2 induces apoptosis of hepatic stellate cells and attenuates liver fibrosis in mice by downregulating miR-23a-5p and miR-28a-5p. Brea R, etal., Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):325-337. doi: 10.1016/j.bbadis.2017.11.001. Epub 2017 Nov 3.
21. Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Buskens CJ, etal., Gastroenterology. 2002 Jun;122(7):1800-7.
22. Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). Campean V, etal., Am J Physiol Renal Physiol 2003 Jul;285(1):F19-32. Epub 2003 Mar 25.
23. Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-alpha in the rat. Candelario-Jalil E, etal., J Pharmacol Exp Ther. 2007 Nov;323(2):488-98. Epub 2007 Aug 17.
24. Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. Carey MA, etal., J Immunol. 2005 Nov 15;175(10):6878-84.
25. Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy. Ceccarelli M, etal., J Cell Mol Med. 2009 Aug;13(8B):2704-12.
26. Association of prostaglandin-endoperoxide synthase 2 gene polymorphisms with asthma and atopy in Chinese children. Chan IH, etal., Allergy. 2007 Jul;62(7):802-9.
27. Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease. Chang JW, etal., Neurobiol Aging. 1996 Sep-Oct;17(5):801-8.
28. Cryptorchidism-induced CFTR down-regulation results in disruption of testicular tight junctions through up-regulation of NF-kappaB/COX-2/PGE2. Chen J, etal., Hum Reprod. 2012 Sep;27(9):2585-97. doi: 10.1093/humrep/des254. Epub 2012 Jul 9.
29. Celecoxib attenuates liver steatosis and inflammation in non-alcoholic steatohepatitis induced by high-fat diet in rats. Chen J, etal., Mol Med Report. 2011 Jun 2. doi: 10.3892/mmr.2011.501.
30. [Expressions of cyclooxygenase-2 and matrix metalloproteinase-2 and airflow obstruction in patients with chronic obstructive pulmonary disease]. Chen Y and Chen P, Zhonghua Jie He He Hu Xi Za Zhi. 2005 May;28(5):324-7.
31. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma. Choi HJ, etal., Hepatogastroenterology. 2009 May-Jun;56(91-92):606-9.
32. FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. Chu S, etal., Mol Hum Reprod. 2002 May;8(5):426-33.
33. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. Chuang YC, etal., J Urol. 2008 Aug;180(2):742-8. Epub 2008 Jun 13.
34. Anti-inflammatory effect of low intensity ultrasound (LIUS) on complete Freund's adjuvant-induced arthritis synovium. Chung JI, etal., Osteoarthritis Cartilage. 2012 Jan 24.
35. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. Cipollone F, etal., JAMA. 2004 May 12;291(18):2221-8.
36. Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression. Colby JK, etal., Neoplasia. 2008 Aug;10(8):782-96.
37. COX-2, but not COX-1, activity is necessary for the induction of perforant path long-term potentiation and spatial learning in vivo. Cowley TR, etal., Eur J Neurosci. 2008 Jun;27(11):2999-3008. Epub 2008 Jun 6.
38. Genetic Variations in Inflammatory Response Genes and Their Association with the Risk of Prostate Cancer. Cui X, etal., Biomed Res Int. 2015;2015:674039. doi: 10.1155/2015/674039. Epub 2015 Dec 14.
39. Prostaglandin-endoperoxide synthase genes COX1 and COX2 - novel modifiers of disease severity in cystic fibrosis patients. Czerska K, etal., J Appl Genet. 2010;51(3):323-30.
40. Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats. de Meira Santos Lima M, etal., Brain Res. 2006 Jul 26;1101(1):117-25. Epub 2006 Jun 15.
41. Cyclooxygenases-1 and -2 are differentially localized to microglia and endothelium in rat EAE and glioma. Deininger MH and Schluesener HJ, J Neuroimmunol. 1999 Mar 1;95(1-2):202-8.
42. Cyclooxygenase (COX)-1 expressing macrophages/microglial cells and COX-2 expressing astrocytes accumulate during oligodendroglioma progression. Deininger MH, etal., Brain Res. 2000 Dec 1;885(1):111-6.
43. Cyclooxygenase-1 and -2 in brains of patients who died with sporadic Creutzfeldt-Jakob disease. Deininger MH, etal., J Mol Neurosci. 2003 Feb;20(1):25-30.
44. Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors. Delannoy E, etal., Cardiovasc Res. 2010 Feb 1;85(3):582-92. Epub 2009 Aug 26.
45. Protective effect of cyclooxygenase-2 (COX-2) inhibitors but not non-selective cyclooxygenase (COX)-inhibitors on ethanol withdrawal-induced behavioural changes. Dhir A, etal., Addict Biol. 2005 Dec;10(4):329-35.
46. Neuroprotective Effect of Cyclooxygenase Inhibitors in ICV-STZ Induced Sporadic Alzheimer's Disease in Rats. Dhull DK, etal., J Mol Neurosci. 2012 Jan;46(1):223-35. Epub 2011 Jun 24.
47. Rat ovulation, implantation and decidualization are severely compromised by COX-2 inhibitors. Diao HL, etal., Front Biosci. 2007 May 1;12:3333-42.
48. Celecoxib has Potent Antitumour Effects as a Single Agent and in Combination with BCG Immunotherapy in a Model of Urothelial Cell Carcinoma. Dovedi SJ, etal., Eur Urol. 2008 Sep;54(3):621-30. Epub 2008 Jan 15.
49. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. DuBois RN, etal., Am J Physiol. 1994 May;266(5 Pt 1):G822-7.
50. Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury. Durrenberger PF, etal., J Peripher Nerv Syst. 2004 Mar;9(1):15-25.
51. Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension. Eizayaga FX, etal., World J Gastroenterol. 2007 Oct 14;13(38):5065-5070.
52. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Ellinger J, etal., Urology. 2008 Jan;71(1):161-7.
53. Glutamine contributes to ameliorate inflammation after renal ischemia/reperfusion injury in rats. Esposito E, etal., Naunyn Schmiedebergs Arch Pharmacol. 2011 May;383(5):493-508. Epub 2011 Mar 11.
54. Dopaminergic but Not Glutamatergic Neurotransmission Is Increased in the Striatum after Selective Cyclooxygenase-2 Inhibition in Normal and Hemiparkinsonian Rats. Fathi Moghaddam H, etal., Basic Clin Pharmacol Toxicol. 2008 Aug 28.
55. Berberine hydrochloride attenuates cyclooxygenase-2 expression in rat small intestinal mucosa during acute endotoxemia. Feng AW, etal., Fitoterapia. 2011 May 27.
56. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Feng L, etal., Arch Biochem Biophys 1993 Dec;307(2):361-8.
57. Glutamine inhibits over-expression of pro-inflammatory genes and down-regulates the nuclear factor kappaB pathway in an experimental model of colitis in the rat. Fillmann H, etal., Toxicology. 2007 Jul 17;236(3):217-26. Epub 2007 Apr 27.
58. Cyclooxygenase-2 inhibition and hypoxia-induced pulmonary hypertension: effects on pulmonary vascular remodeling and contractility. Fredenburgh LE, etal., Trends Cardiovasc Med. 2009 Feb;19(2):31-7.
59. Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Freshwater JD, etal., Diabetes 2002 Jul;51(7):2249-55.
60. Expression of cyclooxygenase-2 in Wilms tumor: immunohistochemical study using tissue microarray methodology. Fridman E, etal., J Urol. 2006 Oct;176(4 Pt 2):1747-50.
61. Local and systemic expression of inducible nitric oxide synthase in comparison with that of cyclooxygenase-2 in rat carrageenin-induced pleurisy. Fujisawa H, etal., Nitric Oxide. 2005 Mar;12(2):80-8.
62. Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor. Funahashi H, etal., Cancer Res. 2007 Aug 1;67(15):7068-71. Epub 2007 Jul 24.
63. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
64. Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma. Gendy AS, etal., J Pediatr Surg. 2011 Jan;46(1):108-14.
65. COX-2 polymorphisms -765G→C and -1195A→G and hepatocellular carcinoma risk. Gharib AF, etal., Gene. 2014 Jun 15;543(2):234-6. doi: 10.1016/j.gene.2014.04.014. Epub 2014 Apr 8.
66. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
67. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Graham GG, etal., Inflammopharmacology. 2013 Jun;21(3):201-32. doi: 10.1007/s10787-013-0172-x. Epub 2013 May 30.
68. Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis. Greenwald M, etal., Curr Med Res Opin. 2011 Oct;27(10):2033-42. Epub 2011 Sep 12.
69. Prognostic Significance and Clinicopathological Associations of COX-2 SNP in Patients with Nonsmall Cell Lung Cancer. Grimminger PP, etal., J Oncol. 2009;2009:139590. Epub 2009 Nov 22.
70. Experimental sepsis-associated encephalopathy is accompanied by altered cerebral blood perfusion and water diffusion and related to changes in cyclooxygenase-2 expression and glial cell morphology but not to blood-brain barrier breakdown. Griton M, etal., Brain Behav Immun. 2020 Jan;83:200-213. doi: 10.1016/j.bbi.2019.10.012. Epub 2019 Oct 14.
71. Selective increase of neuronal cyclooxygenase-2 (COX-2) expression in vulnerable brain regions of rats with experimental Wernicke's encephalopathy: effect of nimesulide. Gu B, etal., Metab Brain Dis. 2008 Jun;23(2):175-87. Epub 2008 May 15.
72. Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection. Guerrero NA, etal., PLoS Negl Trop Dis. 2015 Aug 25;9(8):e0004025. doi: 10.1371/journal.pntd.0004025. eCollection 2015.
73. Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. Guo YS, etal., J Biol Chem 2002 Dec 13;277(50):48755-63.
74. COX-2 up-regulation and vascular smooth muscle contractile hyperreactivity in spontaneous diabetic db/db mice. Guo Z, etal., Cardiovasc Res. 2005 Sep 1;67(4):723-35.
75. Possible role of cyclooxygenase-2 in schistosomal and non-schistosomal-associated bladder cancer. Hammam OA, etal., Medscape J Med. 2008 Mar 11;10(3):60.
76. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. Hammes LS, etal., Gynecol Oncol. 2008 Jun 18.
77. Up-regulation of VEGF, c-fms and COX-2 expression correlates with severity of cervical cancer precursor (CIN) lesions and invasive disease. Hammes LS, etal., Gynecol Oncol. 2008 Sep;110(3):445-51. Epub 2008 Jun 20.
78. Transgenic expression of cyclooxygenase-2 in hepatocytes accelerates endotoxin-induced acute liver failure. Han C, etal., J Immunol. 2008 Dec 1;181(11):8027-35. doi: 10.4049/jimmunol.181.11.8027.
79. Central control of fever and female body temperature by RANKL/RANK. Hanada R, etal., Nature. 2009 Nov 26;462(7272):505-9. doi: 10.1038/nature08596.
80. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors. Hatazawa R, etal., Am J Physiol Gastrointest Liver Physiol. 2007 Oct;293(4):G788-97. Epub 2007 Aug 2.
81. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship. Hayashi S, etal., Biochem Pharmacol. 2011 Oct 1;82(7):755-68. Epub 2011 Jul 2.
82. Effects of a cyclooxygenase 2 inhibitor on fracture healing in a rat model. Herbenick MA, etal., Am J Orthop (Belle Mead NJ). 2008 Jul;37(7):E133-7.
83. Expression of COX-2 is associated with accumulation of p53 in pancreatic cancer: analysis of COX-2 and p53 expression in premalignant and malignant ductal pancreatic lesions. Hermanova M, etal., Eur J Gastroenterol Hepatol. 2008 Aug;20(8):732-9.
84. Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2. Herrerias A, etal., J Inflamm (Lond). 2009 Oct 30;6:30.
85. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Hildebrandt MA, etal., PLoS One. 2010 Aug 25;5(8):e12402.
86. Cyclooxygenase-dependent vasoconstricting factor(s) in remodelled rat femoral arteries. Hirao A, etal., Cardiovasc Res. 2008 Jul 1;79(1):161-8. Epub 2008 May 2.
87. Prostanoids as regulators of innate and adaptive immunity. Hirata T and Narumiya S, Adv Immunol. 2012;116:143-74. doi: 10.1016/B978-0-12-394300-2.00005-3.
88. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Ho WS and Randall MD, Br J Pharmacol. 2007 Mar;150(5):641-51. Epub 2007 Jan 22.
89. Improvements of the algorithm for defining QRS onset and offset in the Pipberger program. Hobel W, etal., Adv Cardiol. 1978;21:181-4.
90. Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy. Holtman L, etal., Epilepsy Res. 2010 Sep;91(1):49-56.
91. Cyclo-oxygenases and prostaglandins in acute inflammatory demyelination of the peripheral nerve. Hu W, etal., Neurology. 2003 Dec 23;61(12):1774-9.
92. Hydrogen supplemented air inhalation reduces changes of prooxidant enzyme and gap junction protein levels after transient global cerebral ischemia in the rat hippocampus. Hugyecz M, etal., Brain Res. 2011 Aug 2;1404:31-8. Epub 2011 Jun 12.
93. Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice. Iadecola C, etal., Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1294-9.
94. Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Innala L, etal., Arthritis Res Ther. 2011 Aug 15;13(4):R131.
95. Role of COX-2 in cough reflex sensitivity to inhaled capsaicin in patients with sinobronchial syndrome. Ishiura Y, etal., Cough. 2010 Aug 9;6:7.
96. COX-2 inhibition attenuates cough reflex sensitivity to inhaled capsaicin in patients with asthma. Ishiura Y, etal., J Investig Allergol Clin Immunol. 2009;19(5):370-4.
97. Role of the tumor necrosis factor-alpha, cyclooxygenase-2, prostaglandin E2, and effect of low-intensity pulsed ultrasound in an in vitro herniated disc resorption model. Iwabuchi S, etal., J Orthop Res. 2008 Sep;26(9):1274-8.
98. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Jelic S, etal., Circulation. 2008 Apr 29;117(17):2270-8. Epub 2008 Apr 14.
99. [Expressions and clinical significances of c-met, c-erbB-2, COX-2, and IL-6 in the biliary tract cancers] Joo HH, etal., Korean J Gastroenterol. 2007 Dec;50(6):370-8.
100. The pathophysiological roles of COX-1 and COX-2 in the intestinal smooth muscle contractility under the anaphylactic condition. Kadowaki H, etal., Biomed Res. 2008 Apr;29(2):113-7.
101. Suppressing inflammatory cascade by cyclo-oxygenase inhibitors attenuates quinolinic acid induced Huntington's disease-like alterations in rats. Kalonia H and Kumar A, Life Sci. 2011 Apr 25;88(17-18):784-91. Epub 2011 Feb 26.
102. Celecoxib after the onset of reperfusion reduces apoptosis in the amygdala. Kaloustian S, etal., Apoptosis. 2007 Nov;12(11):1945-51.
103. Angiotensin II feedback is a regulator of renocortical renin, COX-2, and nNOS expression. Kammerl MC, etal., Am J Physiol Regul Integr Comp Physiol 2002 Jun;282(6):R1613-7.
104. Correlation of COX-2 expression in stromal cells with high stage, high grade, and poor prognosis in urothelial carcinoma of upper urinary tracts. Kang CH, etal., Urology. 2008 Jul;72(1):153-7. Epub 2008 Apr 8.
105. Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus. Kaur BS, etal., Gastroenterology. 2002 Jul;123(1):60-7.
106. Diclofenac, a selective COX-2 inhibitor, inhibits DMH-induced colon tumorigenesis through suppression of MCP-1, MIP-1alpha and VEGF. Kaur J and Sanyal SN, Mol Carcinog. 2011 Jan 25. doi: 10.1002/mc.20736.
107. KEGG: Kyoto Encyclopedia of Genes and Genomes KEGG
108. Protective Effects of Cyclooxygenase-2 Gene Inactivation against Peripheral Nerve Dysfunction and Intraepidermal Nerve Fibers Loss in Experimental Diabetes. Kellogg AP, etal., Diabetes. 2007 Aug 24;.
109. Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice. Kelso ML, etal., BMC Neurosci. 2009 Aug 31;10:108.
110. Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Kennedy BP, etal., Biochem Biophys Res Commun 1993 Dec 15;197(2):494-500.
111. Therapeutic effect of CS-706, a specific cyclooxygenase-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice. Kiguchi K, etal., Mol Cancer Ther. 2007 Jun;6(6):1709-17.
112. Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Kim HW, etal., Mol Psychiatry. 2011 Apr;16(4):419-28. Epub 2009 Dec 29.
113. Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Kim SH, etal., Pharmacogenet Genomics. 2007 Apr;17(4):295-304. doi: 10.1097/01.fpc.0000239977.61841.fe.
114. The COX-2 inhibitor SC-236 exerts anti-inflammatory effects by suppressing phosphorylation of ERK in a murine model. Kim SJ, etal., Life Sci. 2007 Aug 23;81(11):863-72. Epub 2007 Sep 5.
115. Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts. Kim SM, etal., Hepatol Res. 2008 Aug;38(8):800-9. Epub 2008 May 7.
116. Resveratrol prevents development of eosinophilic rhinosinusitis with nasal polyps in a mouse model. Kim SW, etal., Allergy. 2013 Jul;68(7):862-9. doi: 10.1111/all.12132. Epub 2013 Jun 10.
117. Gastrin enhances gastric mucosal integrity through cyclooxygenase-2 upregulation in rats. Komori M, etal., Am J Physiol Gastrointest Liver Physiol 2002 Dec;283(6):G1368-78.
118. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease. Kubo K, etal., Brain Res. 2011 Apr 28;1387:125-33. Epub 2011 Mar 2.
119. COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ. Kulkarni S, etal., BMC Cancer. 2008 Jan 31;8:36.
120. Evidence for cyclooxygenase-2 association with caveolin-3 in primary cultured rat chondrocytes. Kwak JO, etal., J Korean Med Sci. 2006 Feb;21(1):100-6.
121. Meconium aspiration stimulates cyclooxygenase-2 and nitric oxide synthase-2 expression in rat lungs. Kytölä J, etal., Pediatr Res. 2003 May;53(5):731-6. doi: 10.1203/01.PDR.0000059222.68800.1B. Epub 2003 Mar 5.
122. Electroacupuncture inhibits cyclooxygenase-2 up-regulation in rat spinal cord after spinal nerve ligation. Lau WK, etal., Neuroscience. 2008 Aug 13;155(2):463-8. Epub 2008 Jun 14.
123. Effects of celecoxib and nordihydroguaiaretic acid on puromycin aminonucleoside-induced nephrosis in the rat. Lee DW, etal., J Korean Med Sci. 2009 Jan;24 Suppl:S183-8. Epub 2009 Jan 29.
124. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. Lee SM, etal., J Infect Dis. 2008 Aug 15;198(4):525-35.
125. Expression of cyclooxygenase-2, glucose transporter-1 and angiogenesis in gallbladder carcinomas and their impact on prognosis. Legan M, etal., Scand J Gastroenterol. 2009;44(9):1101-8.
126. [The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer]. Li EX, etal., Zhonghua Yi Xue Za Zhi. 2008 Jan 8;88(2):88-91.
127. Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression. Li M, etal., Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2444-55. Epub 2008 Feb 29.
128. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium. Li S, etal., Gynecol Oncol. 2004 Feb;92(2):622-7.
129. Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy. Limsukon A, etal., Chest. 2009 Sep;136(3):924-6.
130. Transactivation of EGFR/PI3K/Akt involved in ATP-induced inflammatory protein expression and cell motility. Lin CC, etal., J Cell Physiol. 2011 Jun 15. doi: 10.1002/jcp.22880.
131. Phase II Trial of Gemcitabine, Irinotecan, and Celecoxib in Patients With Advanced Pancreatic Cancer. Lipton A, etal., J Clin Gastroenterol. 2010 Mar 3.
132. Effect of intramuscular injection of hepatocyte growth factor plasmid DNA with electroporation on bleomycin-induced lung fibrosis in rats. Long X, etal., Chin Med J (Engl). 2007 Aug 20;120(16):1432-7.
133. Cyclooxygenase-2 polymorphisms confer susceptibility to sarcoidosis but are not related to prognosis. Lopez-Campos JL, etal., Respir Med. 2009 Mar;103(3):427-33. Epub 2008 Nov 29.
134. Type 1 Diabetes-Induced Hyper-Responsiveness to 5-Hydroxytryptamine in Rat Pulmonary Arteries via Oxidative Stress and Induction of Cyclooxygenase-2. Lopez-Lopez JG, etal., J Pharmacol Exp Ther. 2011 Jul;338(1):400-7. Epub 2011 Apr 26.
135. Nuclear factor-kappaB-regulated cyclooxygenase-2 expression in surgery-associated paraspinal muscle injury in rats. Lu K, etal., J Neurosurg 2003 Mar;98(2 Suppl):181-7.
136. Cylooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Lucci A, etal., Breast Cancer Res Treat. 2008 Jul 29.
137. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Ma W, etal., Brain Res 2002 May 24;937(1-2):94-9.
138. Cyclooxygenase-2 contributes to functional changes seen on experimental hemorrhagic cystitis induced by ifosfamide in rat urinary bladder. Macedo FY, etal., Cancer Chemother Pharmacol. 2011 Apr;67(4):935-43. Epub 2010 Jul 3.
139. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model. Machado DE, etal., Fertil Steril. 2010 May 15;93(8):2674-9. Epub 2010 Jan 13.
140. DOI, an agonist of 5-HT2A/2C serotonin receptor, alters the expression of cyclooxygenase-2 in the rat parietal cortex. Mackowiak M, etal., J Physiol Pharmacol 2002 Sep;53(3):395-407.
141. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Maher TM, etal., Am J Respir Crit Care Med. 2010 Jul 1;182(1):73-82. Epub 2010 Mar 4.
142. Expression and localization of cyclooxygenase-1 and -2 in human sporadic amyotrophic lateral sclerosis. Maihofner C, etal., Eur J Neurosci. 2003 Sep;18(6):1527-34.
143. Molecular mechanisms regulating the vascular prostacyclin pathways and their adaptation during pregnancy and in the newborn. Majed BH and Khalil RA, Pharmacol Rev. 2012 Jul;64(3):540-82. doi: 10.1124/pr.111.004770. Epub 2012 Jun 7.
144. Cyclooxygenase-2 mRNA expression is associated with c-fos mRNA expression and transient water ADC reduction detected with diffusion MRI during acute focal ischemia in rats. Mancuso A, etal., Brain Res. 2003 Jan 24;961(1):121-30.
145. Polymorphisms rs2745557 in PTGS2 and rs2075797 in PTGER2 are associated with the risk of chronic obstructive pulmonary disease development in a Tunisian cohort. Mani S, etal., Prostaglandins Leukot Essent Fatty Acids. 2021 Mar;166:102252. doi: 10.1016/j.plefa.2021.102252. Epub 2021 Jan 28.
146. Homer1a is a core brain molecular correlate of sleep loss. Maret S, etal., Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20090-5. Epub 2007 Dec 6.
147. Urethane suppresses rat lung inducible cyclooxygenase and nitric oxide synthase mRNA levels. Martinez FE, etal., Inflamm Res. 2000 Dec;49(12):727-31.
148. Insulin suppresses LPS-induced iNOS and COX-2 expression and NF-kappaB activation in alveolar macrophages. Martins JO, etal., Cell Physiol Biochem. 2008;22(1-4):279-86. Epub 2008 Jul 25.
149. Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. Matsunaga A, etal., Eur J Pharmacol. 2007 Jan 5;554(1):12-7. Epub 2006 Oct 20.
150. CGS 21680, an Agonist of the Adenosine (A2A) Receptor, Reduces Progression of Murine Type II Collagen-induced Arthritis. Mazzon E, etal., J Rheumatol. 2011 Oct;38(10):2119-29. Epub 2011 Jul 15.
151. Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors. McCormick DL, etal., Cancer Prev Res (Phila). 2010 Jan;3(1):73-81.
152. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
153. Cyclooxygenase 2 inhibits SAPK activation in neuronal apoptosis. Miller B, etal., Biochem Biophys Res Commun 2003 Jan 24;300(4):884-8.
154. A cyclooxygenase-2 inhibitor ameliorates behavioral impairments induced by striatal administration of epidermal growth factor. Mizuno M, etal., J Neurosci. 2007 Sep 19;27(38):10116-27.
155. Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise. Moon HY, etal., Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):13094-9. doi: 10.1073/pnas.1205535109. Epub 2012 Jul 23.
156. Anti-inflammatory and analgesic actions of etoricoxib (an NSAID) combined with misoprostol. Moraes BM, etal., Inflammopharmacology. 2007 Aug;15(4):175-8.
157. Suppression of tumor formation by a cyclooxygenase-2 inhibitor and a peroxisome proliferator-activated receptor gamma agonist in an in vivo mouse model of spontaneous breast cancer. Mustafa A and Kruger WD, Clin Cancer Res. 2008 Aug 1;14(15):4935-42.
158. A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors. Narasimha A, etal., Prostaglandins Other Lipid Mediat. 2007 Aug;84(1-2):24-33. Epub 2007 Mar 14.
159. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
160. Cyclooxygenases 1 and 2 contribute to peroxynitrite-mediated inflammatory pain hypersensitivity. Ndengele MM, etal., FASEB J. 2008 Sep;22(9):3154-64. Epub 2008 May 22.
161. Cyclooxygenase inhibition in ventilator-induced lung injury. Niitsu T, etal., Anesth Analg. 2011 Jan;112(1):143-9. Epub 2010 Nov 3.
162. Micro-CT imaging analysis for the effect of celecoxib, a cyclooxygenase-2 inhibitor, on inflammatory bone destruction in adjuvant arthritis rats. Noguchi M, etal., J Bone Miner Metab. 2008;26(5):461-8. Epub 2008 Aug 30.
163. Chemoprevention of glandular stomach carcinogenesis through duodenogastric reflux in rats by a COX-2 inhibitor. Oba M, etal., Int J Cancer. 2008 Oct 1;123(7):1491-8.
164. Down-regulation of cyclooxygenase-2 expression but up-regulation of cyclooxygenase-1 in renal carcinomas of the Eker (TSC2 gene mutant) rat model. Okamoto T, etal., Cancer Sci. 2003 Jan;94(1):22-5.
165. Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats. Okayama M, etal., Dig Dis Sci. 2007 Sep;52(9):2095-103. Epub 2007 Apr 12.
166. Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors. Orbe J, etal., Clin Chim Acta. 2006 Jun;368(1-2):138-43. Epub 2006 Feb 3.
167. Expression of cyclooxygenase and lipoxygenase enzymes in sinonasal mucosa of patients with cystic fibrosis. Owens JM, etal., Arch Otolaryngol Head Neck Surg. 2008 Aug;134(8):825-31.
168. [Cyclooxygenase (COX)-2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide] Oyama K, etal., Nippon Shokakibyo Gakkai Zasshi. 2007 Aug;104(8):1183-91.
169. Effect of apocynin treatment on renal expression of COX-2, NOS1, and renin in Wistar-Kyoto and spontaneously hypertensive rats. Paliege A, etal., Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R694-700.
170. Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination. Palumbo S, etal., Prostaglandins Leukot Essent Fatty Acids. 2011 Jul;85(1):29-35. doi: 10.1016/j.plefa.2011.04.001. Epub 2011 May 6.
171. P2X7 receptors on osteoblasts couple to production of lysophosphatidic acid: a signaling axis promoting osteogenesis. Panupinthu N, etal., J Cell Biol. 2008 Jun 2;181(5):859-71. doi: 10.1083/jcb.200708037.
172. Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Pasinetti GM and Aisen PS, Neuroscience. 1998 Nov;87(2):319-24.
173. Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. Patel VA, etal., J Biol Chem 2002 Oct 11;277(41):38915-20.
174. Diet-induced obesity associated with steatosis, oxidative stress, and inflammation in liver. Peng Y, etal., Surg Obes Relat Dis. 2011 Aug 27.
175. Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis. Petkova DK, etal., Histopathology. 2003 Oct;43(4):381-6.
176. Loss of 15-Hydroxyprostaglandin Dehydrogenase Increases Prostaglandin E2 in Pancreatic Tumors. Pham H, etal., Pancreas. 2009 Oct 7.
177. Characterization of the Prostaglandin E2 path way in a Rat Model of Esophageal Adenocarcinoma. Piazuelo E, etal., Curr Cancer Drug Targets. 2011 Oct 27.
178. Functional polymorphism of cyclooxygenase-2 gene (G-765C) in chronic obstructive pulmonary disease patients. Pietras T, etal., Mol Biol Rep. 2011 Jun 8.
179. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
180. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
181. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
182. Increased gene expression and production of spinal cyclooxygenase 1 and 2 during experimental osteoarthritis pain. Prochazkova M, etal., Physiol Res. 2008 Jul 18.
183. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse. Przybylkowski A, etal., Brain Res. 2004 Sep 3;1019(1-2):144-51.
184. [Expression and significance of COX-2 and S-100 positive dendritic cell in laryngeal carcinoma]. Qin G, etal., Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2010 Feb;24(3):101-4.
185. Renal protective effect of chronic inhibition of COX-2 with SC-58236 in streptozotocin-diabetic rats. Quilley J, etal., Am J Physiol Heart Circ Physiol. 2011 Jun;300(6):H2316-22. Epub 2011 Mar 25.
186. Role of GluN2A NMDA receptor in homocysteine-induced prostaglandin E2 release from neurons. Rajagopal S, etal., J Neurochem. 2019 Jul;150(1):44-55. doi: 10.1111/jnc.14775. Epub 2019 Jun 20.
187. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat. Rakotoniaina Z, etal., Naunyn Schmiedebergs Arch Pharmacol. 2008 Sep;378(3):241-51. Epub 2008 Jun 10.
188. Silymarin downregulates COX-2 expression and attenuates hyperlipidemia during NDEA-induced rat hepatocellular carcinoma. Ramakrishnan G, etal., Mol Cell Biochem. 2008 Jun;313(1-2):53-61. Epub 2008 Mar 31.
189. Study on cow ghee versus soybean oil on 7,12-dimethylbenz(a)-anthracene induced mammary carcinogenesis & expression of cyclooxygenase-2 & peroxisome proliferators activated receptor- gamma in rats. Rani R and Kansal VK, Indian J Med Res. 2011 May;133(5):497-503.
190. Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. Rao JS, etal., J Neuroinflammation. 2011 Aug 16;8:101.
191. Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Rao JS, etal., Mol Psychiatry. 2007 Feb;12(2):151-7. Epub 2006 Sep 19.
192. Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Reyes-Gibby CC, etal., Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2636-42. Epub 2009 Sep 22.
193. GOA pipeline RGD automated data pipeline
194. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
195. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
196. Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis. Roca-Ferrer J, etal., Thorax. 2006 Jul;61(7):592-6. Epub 2006 Mar 3.
197. COX-2 expression correlates with survival in patients with osteosarcoma lung metastases. Rodriguez NI, etal., J Pediatr Hematol Oncol. 2008 Jul;30(7):507-12.
198. Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema. Roh GS, etal., Am J Physiol Lung Cell Mol Physiol. 2010 Aug;299(2):L184-91. Epub 2010 May 14.
199. Protective effect of ellagic acid, a natural polyphenolic compound, in a murine model of Crohn's disease. Rosillo MA, etal., Biochem Pharmacol. 2011 Oct 1;82(7):737-45. Epub 2011 Jul 7.
200. Stimulation of tube formation mediated through the prostaglandin EP2 receptor in rat luteal endothelial cells. Sakurai T, etal., J Endocrinol. 2011 Apr;209(1):33-43. Epub 2011 Jan 27.
201. Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease. Sankaran D, etal., Am J Physiol Renal Physiol. 2007 Sep;293(3):F821-30. Epub 2007 May 30.
202. Peroxisome proliferator-activated receptor gamma mediates protection against cyclooxygenase-2-induced gut dysfunction in a rodent model of mesenteric ischemia/reperfusion. Sato N, etal., Shock. 2005 Nov;24(5):462-9.
203. Alvimopan and COX-2 inhibition reverse opioid and inflammatory components of postoperative ileus. Schmidt J, etal., Neurogastroenterol Motil. 2008 Jun;20(6):689-99. Epub 2008 Feb 4.
204. Protective Role of Cyclooxygenase (COX)-2 in Experimental Lung Injury: Evidence of a Lipoxin A(4)-Mediated Effect. Scully M, etal., J Surg Res. 2011 Mar 16.
205. Proanthocyanidins inhibit in vitro and in vivo growth of human non-small cell lung cancer cells by inhibiting the prostaglandin E(2) and prostaglandin E(2) receptors. Sharma SD, etal., Mol Cancer Ther. 2010 Mar;9(3):569-80. doi: 10.1158/1535-7163.MCT-09-0638. Epub 2010 Feb 9.
206. Cyclooxygenase-2 gene polymorphisms in an Australian population: association of the -1195G > A promoter polymorphism with mild asthma. Shi J, etal., Clin Exp Allergy. 2008 Jun;38(6):913-20. Epub 2008 Apr 11.
207. Pathophysiology of motility dysfunction in bowel obstruction: role of stretch-induced COX-2. Shi XZ, etal., Am J Physiol Gastrointest Liver Physiol. 2011 Jan;300(1):G99-G108. Epub 2010 Nov 4.
208. Sarcoidosis and interstitial pulmonary fibrosis; two distinct disorders or two ends of the same spectrum. Shigemitsu H and Azuma A, Curr Opin Pulm Med. 2011 Jun 15.
209. Involvement of cyclooxygenase-1 and -2 in the sciatic nerve of rats with experimental autoimmune neuritis. Shin T, etal., Immunol Invest. 2003 Aug;32(3):123-30.
210. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. Shiraishi Y, etal., J Immunol. 2008 Jan 1;180(1):541-9.
211. COX-2 is not required for the development of murine chronic pancreatitis. Silva A, etal., Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G968-75. Epub 2011 Mar 3.
212. Substance P upregulates cyclooxygenase-2 and prostaglandin E metabolite by activating ERK1/2 and NF-kappaB in a mouse model of burn-induced remote acute lung injury. Sio SW, etal., J Immunol. 2010 Nov 15;185(10):6265-76. Epub 2010 Oct 6.
213. Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma. Sousa A, etal., Thorax. 1997 Nov;52(11):940-5.
214. Cyclooxygenase-2 expression: does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma? Sozen S, etal., Int Urol Nephrol. 2008;40(2):295-301.
215. Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population. Srivastava K, etal., J Gastroenterol. 2009;44(7):774-80. Epub 2009 May 20.
216. Celecoxib, a selective cyclooxygenase-2 inhibitor, attenuates renal injury in a rat model of Cisplatin-induced nephrotoxicity. Suddek GM, etal., Chemotherapy. 2011;57(4):321-6. Epub 2011 Sep 1.
217. Effects of manganese complexes of curcumin and diacetylcurcumin on kainic acid-induced neurotoxic responses in the rat hippocampus. Sumanont Y, etal., Biol Pharm Bull. 2007 Sep;30(9):1732-9.
218. LY294002 inhibits glucocorticoid-induced COX-2 gene expression in cardiomyocytes through a phosphatidylinositol 3 kinase-independent mechanism. Sun H, etal., Toxicol Appl Pharmacol. 2008 Jun 4.
219. Functional effects and gender association of COX-2 gene polymorphism G-765C in bronchial asthma. Szczeklik W, etal., J Allergy Clin Immunol. 2004 Aug;114(2):248-53.
220. Inhibition of cyclooxygenase-2 enhances myocardial damage in a mouse model of viral myocarditis. Takahashi T, etal., Life Sci. 2005 Nov 26;78(2):195-204. Epub 2005 Aug 16.
221. Depression of cyclooxygenase-2 induction in aortas of rats with type 1 and type 2 diabetes mellitus. Takahashi Y and Wakabayashi I, Eur J Pharmacol. 2008 Jul 31.
222. Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats. Takata H, etal., Diabetes Obes Metab. 2011 Sep 23. doi: 10.1111/j.1463-1326.2011.01499.x.
223. Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. Tang TC, etal., World J Gastroenterol. 2005 Apr 7;11(13):1896-902. doi: 10.3748/wjg.v11.i13.1896.
224. Post-training cyclooxygenase-2 (COX-2) inhibition impairs memory consolidation. Teather LA, etal., Learn Mem 2002 Jan-Feb;9(1):41-7.
225. Cyclooxygenase-2 contributes to VX-induced cell death in cultured cortical neurons. Tenn CC, etal., Toxicol Lett. 2012 Jan 28;210(1):71-77.
226. Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents. Testa M, etal., J Appl Physiol. 2007 Oct;103(4):1412-8. Epub 2007 Aug 2.
227. Chemopreventive action of diclofenac in dimethybenzanthracene induced lung cancer in female Wistar rat. Thakur P and Sanyal SN, J Environ Pathol Toxicol Oncol. 2010;29(3):255-65.
228. Epithelial COX-2 expression is not regulated by nitric oxide in rodent renal cortex. Theilig F, etal., Hypertension 2002 Apr;39(4):848-53.
229. [A cyclooxygenase-2 selective inhibitor worsens respiratory function and enhances mast cell activity in ovalbumin-sensitized mice]. Torres R, etal., Arch Bronconeumol. 2009 Apr;45(4):162-7. Epub 2009 Apr 1.
230. Expression of leukotriene biosynthetic enzymes in tonsillar tissue of children with obstructive sleep apnea: a prospective nonrandomized study. Tsaoussoglou M, etal., JAMA Otolaryngol Head Neck Surg. 2014 Oct;140(10):944-50. doi: 10.1001/jamaoto.2014.1936.
231. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Tsujii M, etal., Cell. 1998 May 29;93(5):705-16.
232. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Tu B and Bazan NG, Exp Neurol 2003 Feb;179(2):167-75.
233. CDX2, COX2 and MUC2 expressions in Barrett's esophagus: can they be useful in determination of the dysplasia? Turkmen IC, etal., Turk Patoloji Derg. 2012;28(3):251-8. doi: 10.5146/tjpath.2012.01132.
234. Upregulation of cyclooxygenase-2 by motorcycle exhaust particulate-induced reactive oxygen species enhances rat vascular smooth muscle cell proliferation. Tzeng HP, etal., Chem Res Toxicol. 2007 Aug;20(8):1170-6. Epub 2007 Jul 24.
235. Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Valdes AM, etal., Arthritis Rheum. 2004 Aug;50(8):2497-507.
236. Prevention by celecoxib of secondary hyperalgesia induced by formalin in rats. Veiga AP, etal., Life Sci. 2004 Oct 22;75(23):2807-17.
237. Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. Visscher DW, etal., J Natl Cancer Inst. 2008 Mar 19;100(6):421-7. Epub 2008 Mar 11.
238. Cyclooxygenase 2 pathway mediates IL-1beta regulation of IL-1alpha, -1beta, and IL-6 mRNA levels in Leydig cell progenitors. Walch L and Morris PL, Endocrinology 2002 Sep;143(9):3276-83.
239. Selective cyclooxygenase-2 inhibition upregulates renal cortical alpha V integrin expression. Waldner C, etal., Nephron Exp Nephrol 2003;93(2):e72.
240. Lead induces COX-2 expression in glial cells in a NFAT-dependent, AP-1/NF¿B-independent manner. Wei J, etal., Toxicology. 2014 Nov 5;325:67-73. doi: 10.1016/j.tox.2014.08.012. Epub 2014 Sep 2.
241. COX2 inhibition reduces aortic valve calcification in vivo. Wirrig EE, etal., Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):938-47. doi: 10.1161/ATVBAHA.114.305159. Epub 2015 Feb 26.
242. Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model. Woditschka S, etal., Breast Cancer Res. 2008;10(1):R18. Epub 2008 Feb 15.
243. Pivotal role of protein kinase Cdelta in angiotensin II-induced endothelial cyclooxygenase-2 expression: a link to vascular inflammation. Wong SL, etal., Arterioscler Thromb Vasc Biol. 2011 May;31(5):1169-76. doi: 10.1161/ATVBAHA.110.216044. Epub 2011 Feb 10.
244. Suppressing cyclooxygenase-2 prevents nonalcoholic and inhibits apoptosis of hepatocytes that are involved in the Akt/p53 signal pathway. Wu J, etal., Biochem Biophys Res Commun. 2016 Jan 22;469(4):1034-40. doi: 10.1016/j.bbrc.2015.12.096. Epub 2015 Dec 23.
245. Expression and cellular localization of cyclooxygenases and prostaglandin E synthases in the hemorrhagic brain. Wu T, etal., J Neuroinflammation. 2011 Mar 8;8:22.
246. Co-overexpression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 adversely affects the postoperative survival in non-small cell lung cancer. Wu YC, etal., J Thorac Oncol. 2010 Aug;5(8):1167-74.
247. [The effect of nitric oxide inhalation on the expression of COX-2 and toll-like receptor 4 in rat acute lung injury induced by lipopolysaccharide]. Wu YW, etal., Zhonghua Jie He He Hu Xi Za Zhi. 2009 Feb;32(2):111-4.
248. A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis. Xaubet A, etal., Sarcoidosis Vasc Diffuse Lung Dis. 2010 Jul;27(2):121-30.
249. [Effect of letrozole on endometrosis and apoptosis of ectopic endometrial cells in rats]. Xia X, etal., Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Jan;38(1):54-9. doi: 10.3969/j.issn.1672-7347.2013.01.010.
250. Down-regulated CFTR During Aging Contributes to Benign Prostatic Hyperplasia. Xie C, etal., J Cell Physiol. 2015 Aug;230(8):1906-15. doi: 10.1002/jcp.24921.
251. [Association between single nucleotide polymorphisms in the promoter of cyclooxygenase COX-2 gene and hereditary susceptibility to pancreatic cancer]. Xu DK, etal., Zhonghua Yi Xue Za Zhi. 2008 Jul 22;88(28):1961-5.
252. Immediate-early MEK-1-dependent stabilization of rat smooth muscle cell cyclooxygenase-2 mRNA by Galpha(q)-coupled receptor signaling. Xu K, etal., J Biol Chem 2000 Jul 28;275(30):23012-9.
253. Expression pattern of cyclooxygenase-2 in normal rat epidermis and pilosebaceous unit during hair cycle. Xu Y, etal., Acta Histochem Cytochem. 2008 Dec 27;41(6):157-63. Epub 2008 Oct 28.
254. Involvement of hypothalamic cyclooxygenase-2, interleukin-1ß and melanocortin in the development of docetaxel-induced anorexia in rats. Yamamoto K, etal., Toxicology. 2012 Dec 16;302(2-3):190-6. doi: 10.1016/j.tox.2012.07.015. Epub 2012 Aug 4.
255. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition. Yang H, etal., Clin Cancer Res. 2008 Apr 1;14(7):2236-44.
256. A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2. Yeoh AS, etal., Mol Cancer Ther. 2007 Aug;6(8):2319-27.
257. The protective role of Kangen-karyu against fructose-induced metabolic syndrome in a rat model. Yokozawa T, etal., J Pharm Pharmacol. 2007 Sep;59(9):1271-8.
258. Preferential localization of prostamide/prostaglandin F synthase in myelin sheaths of the central nervous system. Yoshikawa K, etal., Brain Res. 2011 Jan 7;1367:22-32. doi: 10.1016/j.brainres.2010.10.019. Epub 2010 Oct 13.
259. Expression of cyclooxygenase-1 and -2 in human breast cancer. Yoshimura N, etal., Surg Today. 2003;33(11):805-11.
260. Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder. Youssef RF, etal., J Urol. 2011 Mar;185(3):1112-7. Epub 2011 Jan 21.
261. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats. Yu J, etal., Liver Int. 2008 Apr 23.
262. Cyclooxygenase-2 overexpression inhibits platelet-derived growth factor-induced mesangial cell proliferation through induction of the tumor suppressor gene p53 and the cyclin-dependent kinase inhibitors p21waf-1/cip-1 and p27kip-1. Zahner G, etal., J Biol Chem 2002 Mar 22;277(12):9763-71.
263. Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma. Zeng W, etal., PLoS One. 2014 Apr 23;9(4):e95826. doi: 10.1371/journal.pone.0095826. eCollection 2014.
264. Garlic Oil Suppressed Nitrosodiethylamine-Induced Hepatocarcinoma in Rats by Inhibiting PI3K-AKT-NF-κB Pathway. Zhang CL, etal., Int J Biol Sci. 2015 Apr 25;11(6):643-51. doi: 10.7150/ijbs.10785. eCollection 2015.
265. Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD. Zhang Q, etal., J Am Soc Nephrol. 2011 Apr;22(4):664-72. Epub 2011 Feb 18.
266. [The effect of nimesulide on learning and memory function after serve traumatic brain injury in rats]. Zhang T and Zhang YX, Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Jul;42(4):498-502.
267. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Zhang X, etal., Gastroenterology. 2005 Aug;129(2):565-76.
268. The effect of adrenomedullin on the L-type calcium current in myocytes from septic shock rats: Signaling pathway. Zhang XH, etal., Am J Physiol Heart Circ Physiol. 2007 Aug 31;.
269. Interaction of cyclooxygenase-2 variants and smoking in pancreatic cancer: a possible role of nucleophosmin. Zhao D, etal., Gastroenterology. 2009 May;136(5):1659-68.
270. Cyclooxygenase-2 expression during immortalization and breast cancer progression. Zhao X, etal., Cancer Res. 2008 Jan 15;68(2):467-75. doi: 10.1158/0008-5472.CAN-07-0782.
271. Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/AMPK signaling pathway in vivo. Zheng L, etal., Biomed Pharmacother. 2018 Jan;97:481-488. doi: 10.1016/j.biopha.2017.10.153. Epub 2017 Nov 6.
Additional References at PubMed
PMID:1380156   PMID:1419907   PMID:1556140   PMID:7592599   PMID:7947975   PMID:8352945   PMID:8945508   PMID:9545330   PMID:10385625   PMID:10783317   PMID:10987272   PMID:11245490  
PMID:11809702   PMID:11849824   PMID:11961302   PMID:12021206   PMID:12050186   PMID:12093889   PMID:12160205   PMID:12167602   PMID:12185016   PMID:12355421   PMID:12388434   PMID:12388444  
PMID:12408753   PMID:12429553   PMID:12429810   PMID:12431630   PMID:12452059   PMID:12467530   PMID:12478407   PMID:12511556   PMID:12560203   PMID:12576462   PMID:12664616   PMID:12724285  
PMID:12735864   PMID:12749384   PMID:12751753   PMID:12761246   PMID:12811798   PMID:12821538   PMID:12835322   PMID:12839936   PMID:12851252   PMID:12855701   PMID:12871573   PMID:12882915  
PMID:12888618   PMID:12900348   PMID:12912810   PMID:12918117   PMID:12925531   PMID:13129852   PMID:14499419   PMID:14530261   PMID:14613912   PMID:14633140   PMID:14643175   PMID:14684367  
PMID:14684611   PMID:15026129   PMID:15028765   PMID:15033806   PMID:15094475   PMID:15158123   PMID:15182944   PMID:15210717   PMID:15237442   PMID:15340111   PMID:15465891   PMID:15471850  
PMID:15501196   PMID:15525649   PMID:15525691   PMID:15526382   PMID:15548426   PMID:15550559   PMID:15569325   PMID:15613619   PMID:15633603   PMID:15644490   PMID:15681847   PMID:15685372  
PMID:15713628   PMID:15778400   PMID:15795519   PMID:15800925   PMID:15808647   PMID:15838313   PMID:15854663   PMID:15856452   PMID:15917189   PMID:15935072   PMID:15964853   PMID:15979590  
PMID:16002525   PMID:16008526   PMID:16083499   PMID:16110275   PMID:16140209   PMID:16189289   PMID:16221213   PMID:16323955   PMID:16339820   PMID:16357083   PMID:16373578   PMID:16393343  
PMID:16413500   PMID:16427196   PMID:16492981   PMID:16499924   PMID:16513083   PMID:16514433   PMID:16546299   PMID:16552365   PMID:16567054   PMID:16568149   PMID:16569634   PMID:16572115  
PMID:16597606   PMID:16603590   PMID:16619262   PMID:16622181   PMID:16622306   PMID:16644518   PMID:16646980   PMID:16721810   PMID:16777990   PMID:16780881   PMID:16804969   PMID:16809483  
PMID:16820795   PMID:16837093   PMID:16837651   PMID:16893539   PMID:16935468   PMID:16935907   PMID:16995982   PMID:17043228   PMID:17061049   PMID:17084486   PMID:17175107   PMID:17196338  
PMID:17221297   PMID:17234889   PMID:17244895   PMID:17307294   PMID:17318410   PMID:17382352   PMID:17441341   PMID:17505916   PMID:17511027   PMID:17537839   PMID:17539917   PMID:17560944  
PMID:17581922   PMID:17607546   PMID:17615156   PMID:17622965   PMID:17634395   PMID:17669705   PMID:17704286   PMID:17716650   PMID:17763946   PMID:17766473   PMID:17855367   PMID:17901979  
PMID:17916350   PMID:17929312   PMID:17959708   PMID:17962899   PMID:17977909   PMID:17984113   PMID:18028778   PMID:18034350   PMID:18079588   PMID:18094072   PMID:18095163   PMID:18218685  
PMID:18292448   PMID:18297109   PMID:18335410   PMID:18344592   PMID:18414395   PMID:18452714   PMID:18515110   PMID:18534982   PMID:18543083   PMID:18621015   PMID:18650268   PMID:18684886  
PMID:18688715   PMID:18707853   PMID:18714024   PMID:18723875   PMID:18786748   PMID:18814970   PMID:18843091   PMID:18946499   PMID:18992713   PMID:19037103   PMID:19056763   PMID:19141058  
PMID:19144694   PMID:19145780   PMID:19155631   PMID:19184357   PMID:19233864   PMID:19239908   PMID:19246637   PMID:19247274   PMID:19327173   PMID:19356723   PMID:19383433   PMID:19444941  
PMID:19449290   PMID:19467272   PMID:19483106   PMID:19505386   PMID:19515980   PMID:19591013   PMID:19609832   PMID:19625688   PMID:19628672   PMID:19632905   PMID:19657099   PMID:19679653  
PMID:19723084   PMID:19764341   PMID:19846045   PMID:19861503   PMID:19912740   PMID:19937640   PMID:19959193   PMID:20032084   PMID:20083630   PMID:20091889   PMID:20134354   PMID:20219444  
PMID:20333648   PMID:20411591   PMID:20448152   PMID:20534845   PMID:20549385   PMID:20607198   PMID:20610829   PMID:20735829   PMID:20814068   PMID:20826536   PMID:20977452   PMID:21038659  
PMID:21066890   PMID:21164135   PMID:21186597   PMID:21192429   PMID:21239635   PMID:21262218   PMID:21296955   PMID:21323895   PMID:21355315   PMID:21394197   PMID:21402727   PMID:21428715  
PMID:21506880   PMID:21526453   PMID:21584750   PMID:21609430   PMID:21613413   PMID:21640730   PMID:21679927   PMID:21688048   PMID:21716255   PMID:21802455   PMID:21812273   PMID:21856910  
PMID:21885043   PMID:21932136   PMID:21951274   PMID:21999702   PMID:22142485   PMID:22174936   PMID:22219191   PMID:22387750   PMID:22446402   PMID:22489918   PMID:22523381   PMID:22564588  
PMID:22575043   PMID:22579820   PMID:22613973   PMID:22617488   PMID:22767315   PMID:22791338   PMID:22822059   PMID:22859375   PMID:22898625   PMID:22932114   PMID:22941198   PMID:23002358  
PMID:23034271   PMID:23240616   PMID:23254481   PMID:23306170   PMID:23388481   PMID:23401543   PMID:23423254   PMID:23429494   PMID:23458502   PMID:23515587   PMID:23587942   PMID:23609497  
PMID:23859035   PMID:23877023   PMID:23973752   PMID:23975340   PMID:24064301   PMID:24089527   PMID:24136226   PMID:24210203   PMID:24226522   PMID:24260171   PMID:24260743   PMID:24291639  
PMID:24354410   PMID:24462674   PMID:24559584   PMID:24614038   PMID:24740788   PMID:24773364   PMID:24796880   PMID:24815169   PMID:24841674   PMID:24914375   PMID:25058273   PMID:25070591  
PMID:25080527   PMID:25123248   PMID:25143455   PMID:25216050   PMID:25303727   PMID:25388440   PMID:25400168   PMID:25506925   PMID:25542758   PMID:25635769   PMID:25648833   PMID:25700020  
PMID:25736434   PMID:25811420   PMID:25841778   PMID:25846103   PMID:25989136   PMID:26009769   PMID:26123748   PMID:26241029   PMID:26276312   PMID:26335727   PMID:26466383   PMID:26514267  
PMID:26543049   PMID:26610611   PMID:26612417   PMID:26685759   PMID:26724476   PMID:26824492   PMID:27178425   PMID:27580512   PMID:27642067   PMID:27686454   PMID:27874832   PMID:27923787  
PMID:28352129   PMID:28451639   PMID:28508833   PMID:28642034   PMID:28642262   PMID:28688903   PMID:28770648   PMID:28797762   PMID:28826906   PMID:28933223   PMID:29073723   PMID:29436670  
PMID:29580751   PMID:29614314   PMID:29662056   PMID:29700115   PMID:30292829   PMID:30736955   PMID:30778877   PMID:30794693   PMID:30938133   PMID:31380437   PMID:32204021   PMID:32311346  
PMID:32799674   PMID:32909857   PMID:34610503   PMID:34841988   PMID:35172004   PMID:35396693   PMID:35537317   PMID:35969208   PMID:36189462   PMID:36586043   PMID:36768450   PMID:37059378  
PMID:37562566   PMID:38286397  


Genomics

Comparative Map Data
Ptgs2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81364,714,063 - 64,722,320 (+)NCBIGRCr8GRCr8GRCr8
GRCr8 Ensembl1364,713,619 - 64,722,320 (+)EnsemblGRCr8
mRatBN7.21362,163,936 - 62,172,193 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1362,163,932 - 62,172,188 (+)EnsemblmRatBN7.2
UTH_Rnor_SHR_Utx1364,798,537 - 64,804,239 (+)NCBIUTH_Rnor_SHR_UtxUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01366,083,346 - 66,089,057 (+)NCBIUTH_Rnor_SHRSP_BbbUtx_1.0UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01363,344,882 - 63,350,588 (+)NCBIUTH_Rnor_WKY_Bbb_1.0UTH_Rnor_WKY_Bbb_1.0
Rnor_6.01367,351,230 - 67,356,920 (+)NCBIRnor_6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1367,351,087 - 67,359,335 (+)Ensemblrn6Rnor6.0
Rnor_5.01372,315,959 - 72,324,483 (+)NCBIRnor_5.0Rnor_5.0rn5
RGSC_v3.41364,427,288 - 64,432,978 (+)NCBIRGSC_v3.4RGSC_v3.4rn4
Celera1362,129,439 - 62,135,131 (+)NCBICelera
RGSC_v3.11364,441,245 - 64,449,480 (+)NCBI
Cytogenetic Map13q21NCBI
PTGS2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381186,671,791 - 186,680,423 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1186,671,791 - 186,680,922 (-)Ensemblhg38GRCh38
GRCh371186,640,923 - 186,649,555 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361184,907,592 - 184,916,179 (-)NCBIBuild 36Build 36hg18NCBI36
Build 341183,372,625 - 183,381,213NCBI
Celera1159,751,694 - 159,760,309 (-)NCBICelera
Cytogenetic Map1q31.1NCBI
HuRef1157,875,712 - 157,884,327 (-)NCBIHuRef
CHM1_11188,062,673 - 188,071,288 (-)NCBICHM1_1
T2T-CHM13v2.01186,026,616 - 186,035,248 (-)NCBIT2T-CHM13v2.0
Ptgs2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391149,975,851 - 149,983,978 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1149,975,782 - 149,983,978 (+)EnsemblGRCm39 EnsemblGRCm39
GRCm381150,100,031 - 150,108,234 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1150,100,031 - 150,108,227 (+)Ensemblmm10GRCm38
MGSCv371151,947,254 - 151,955,147 (+)NCBIMGSCv37MGSCv37mm9NCBIm37
MGSCv361151,862,342 - 151,870,235 (+)NCBIMGSCv36mm8
Celera1152,546,728 - 152,554,611 (+)NCBICelera
Cytogenetic Map1G1NCBI
cM Map163.84NCBI
Ptgs2
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495540625,079,945 - 25,086,171 (-)Ensembl
ChiLan1.0NW_00495540625,077,988 - 25,086,259 (-)NCBIChiLan1.0ChiLan1.0
PTGS2
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2163,030,462 - 63,041,820 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan1162,713,923 - 62,723,110 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01162,205,534 - 162,214,130 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11166,355,845 - 166,364,517 (-)NCBIPanPan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1166,355,845 - 166,364,519 (-)EnsemblpanPan2panpan1.1
PTGS2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1719,668,079 - 19,674,903 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl719,668,082 - 19,674,903 (-)EnsemblcanFam3CanFam3.1
Dog10K_Boxer_Tasha719,190,741 - 19,197,565 (-)NCBIDog10K_Boxer_TashaDog10K_Boxer_Tasha
ROS_Cfam_1.0719,405,501 - 19,412,325 (-)NCBIROS_Cfam_1.0ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl719,405,504 - 19,412,176 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1719,311,510 - 19,318,356 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0719,420,827 - 19,427,651 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0719,552,954 - 19,559,778 (-)NCBIUU_Cfam_GSD_1.0UU_Cfam_GSD_1.0
Ptgs2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440934485,975,505 - 85,982,237 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049364813,822,251 - 3,828,086 (+)EnsemblSpeTri2.0 Ensembl
SpeTri2.0NW_0049364813,821,564 - 3,828,086 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
PTGS2
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl9127,850,015 - 127,858,884 (-)EnsemblsusScr11Sscrofa11.1
Sscrofa11.19127,850,164 - 127,858,866 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.29140,251,667 - 140,260,362 (-)NCBISscrofa10.2Sscrofa10.2susScr3
PTGS2
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.12542,733,535 - 42,742,463 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl2542,734,771 - 42,742,429 (+)EnsemblChlSab1.1 EnsemblchlSab2Vervet-AGM
Vero_WHO_p1.0NW_02366605543,903,786 - 43,913,892 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Ptgs2
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_0046248146,897,857 - 6,903,728 (+)EnsemblHetGla_female_1.0 EnsemblhetGla2HetGla_female_1.0 Ensembl
HetGla 1.0NW_0046248146,897,818 - 6,904,890 (+)NCBIHetGla 1.0HetGla 1.0hetGla2
Ptgs2
(Rattus rattus - black rat)
Black Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rrattus_CSIRO_v11029,593,573 - 29,601,879 (+)NCBIRrattus_CSIRO_v1

Variants

.
Variants in Ptgs2
61 total Variants
miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:141
Count of miRNA genes:92
Interacting mature miRNAs:118
Transcripts:ENSRNOT00000003567
Prediction methods:Miranda, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCr8)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
1298066Bp159Blood pressure QTL 1590.004arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)134863963493639634Rat
10755495Bp387Blood pressure QTL 3873.78arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)133721624190057603Rat
1354655Bp241Blood pressure QTL 2413.9arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1338975045103588154Rat
70220Bp55Blood pressure QTL 555.75arterial blood pressure trait (VT:2000000)blood pressure measurement (CMO:0000003)133992469384924693Rat
71119Thym2Thymus enlargement QTL 23.8thymus mass (VT:0004954)thymus weight to body weight ratio (CMO:0000612)134874981487285480Rat
61391Bp5Blood pressure QTL 55.6arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)132485392569853925Rat
4889861Pur29Proteinuria QTL 2913.80.005urine total protein amount (VT:0000032)urine total protein excretion rate (CMO:0000756)133996821183286298Rat
619615Bp80Blood pressure QTL 800.0354arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)13742179187286911Rat
61340Bp25Blood pressure QTL 254.20.004arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)133708798382087983Rat
1581573Uae36Urinary albumin excretion QTL 36urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)13600200888706694Rat
1549897Stresp12Stress response QTL 123.35stress-related behavior trait (VT:0010451)number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960)134098358585983585Rat
724564Uae11Urinary albumin excretion QTL 115.7urine albumin amount (VT:0002871)urine albumin level (CMO:0000130)134735425894285672Rat
7207885Glom27Glomerulus QTL 273.9kidney glomerulus integrity trait (VT:0010546)kidney crescentic glomeruli count to kidney normal glomeruli count ratio (CMO:0002139)1321120177109350286Rat
738026Lnnr5Liver neoplastic nodule remodeling QTL 53.29liver integrity trait (VT:0010547)liver remodeling tumorous lesion number (CMO:0001461)136242459288113509Rat
1558644Cm45Cardiac mass QTL 453.60.002heart mass (VT:0007028)heart wet weight (CMO:0000069)132624480871244808Rat
70181BpQTLcluster11Blood pressure QTL cluster 116.922arterial blood pressure trait (VT:2000000)absolute change in mean arterial blood pressure (CMO:0000533)133379409678794096Rat
61349Bp31Blood pressure QTL 315.75arterial blood pressure trait (VT:2000000)blood pressure measurement (CMO:0000003)133992469384924693Rat
1576318Schws5Schwannoma susceptibility QTL 50.0351nervous system integrity trait (VT:0010566)post-insult time to trigeminal nerve neurilemmoma formation (CMO:0002019)1364497900109350286Rat
2303563Bw89Body weight QTL 896body mass (VT:0001259)body weight (CMO:0000012)133483494779834947Rat
1354621Rf47Renal function QTL 473.7kidney renin amount (VT:0010559)kidney renin level (CMO:0002166)1311081740103588154Rat
1581554Pur11Proteinuria QTL 11urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)13600200888706694Rat
12879477Bp401Blood pressure QTL 401arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)133981472684814726Rat
1331750Bp220Blood pressure QTL 2202.98arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)133996821184968211Rat
6893338Cm76Cardiac mass QTL 7600.99heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)132624480871244808Rat
12879475Bp400Blood pressure QTL 400arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1364375743109350286Rat
11530006Niddm72Non-insulin dependent diabetes mellitus QTL 720.001blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)133828629883286298Rat
1354666Bp244Blood pressure QTL 2444.9arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)131103588154Rat

Markers in Region
Ptgs2  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21362,167,881 - 62,168,027 (+)MAPPERmRatBN7.2
Rnor_6.01367,355,032 - 67,355,177NCBIRnor6.0
Rnor_5.01372,320,172 - 72,320,317UniSTSRnor5.0
RGSC_v3.41364,431,090 - 64,431,235UniSTSRGSC3.4
Celera1362,133,243 - 62,133,388UniSTS
Cytogenetic Map13q21UniSTS
PMC27868P2  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21362,168,413 - 62,169,075 (+)MAPPERmRatBN7.2
Rnor_6.01367,355,564 - 67,356,225NCBIRnor6.0
Rnor_5.01372,320,704 - 72,321,365UniSTSRnor5.0
RGSC_v3.41364,431,622 - 64,432,283UniSTSRGSC3.4
Celera1362,133,775 - 62,134,436UniSTS
Cytogenetic Map13q21UniSTS
Ptgs2  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21362,168,415 - 62,169,644 (+)MAPPERmRatBN7.2
Rnor_6.01367,355,566 - 67,356,794NCBIRnor6.0
Rnor_5.01372,320,706 - 72,321,934UniSTSRnor5.0
RGSC_v3.41364,431,624 - 64,432,852UniSTSRGSC3.4
Celera1362,133,777 - 62,135,005UniSTS
Cytogenetic Map13q21UniSTS


Genetic Models
This gene Ptgs2 is modified in the following models/strains:
SS-Ptgs2em1Mcwi     SS-Ptgs2em2Mcwi    


Expression

RNA-SEQ Expression

alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
respiratory system
sensory system
visual system
16 11 66 164 90 89 58 87 58 6 347 185 11 143 80 92 31 17 17

Sequence


Ensembl Acc Id: ENSRNOT00000003567   ⟹   ENSRNOP00000003567
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl1364,713,986 - 64,722,320 (+)Ensembl
mRatBN7.2 Ensembl1362,163,932 - 62,172,188 (+)Ensembl
Rnor_6.0 Ensembl1367,351,087 - 67,359,335 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000137645   ⟹   ENSRNOP00000112166
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr8 Ensembl1364,713,619 - 64,722,320 (+)Ensembl
RefSeq Acc Id: NM_017232   ⟹   NP_058928
RefSeq Status: VALIDATED
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81364,714,063 - 64,722,320 (+)NCBI
mRatBN7.21362,163,936 - 62,172,193 (+)NCBI
Rnor_6.01367,351,230 - 67,356,920 (+)NCBI
Rnor_5.01372,315,959 - 72,324,483 (+)NCBI
RGSC_v3.41364,427,288 - 64,432,978 (+)RGD
Celera1362,129,439 - 62,135,131 (+)RGD
Sequence:
RefSeq Acc Id: NP_058928   ⟸   NM_017232
- Peptide Label: precursor
- UniProtKB: Q64379 (UniProtKB/Swiss-Prot),   Q925V4 (UniProtKB/Swiss-Prot),   P35355 (UniProtKB/Swiss-Prot),   A6ICR0 (UniProtKB/TrEMBL),   Q63124 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSRNOP00000003567   ⟸   ENSRNOT00000003567
Ensembl Acc Id: ENSRNOP00000112166   ⟸   ENSRNOT00000137645
Protein Domains
EGF-like

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P35355-F1-model_v2 AlphaFold P35355 1-604 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13698878
Promoter ID:EPDNEW_R9403
Type:single initiation site
Name:Ptgs2_1
Description:prostaglandin-endoperoxide synthase 2
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01367,351,086 - 67,351,146EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:620349 AgrOrtholog
BioCyc Gene G2FUF-17948 BioCyc
BioCyc Pathway PWY66-374 [C20 prostanoid biosynthesis] BioCyc
BioCyc Pathway Image PWY66-374 BioCyc
Ensembl Genes ENSRNOG00000002525 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000003567 ENTREZGENE
  ENSRNOT00000003567.5 UniProtKB/Swiss-Prot
Gene3D-CATH 1.10.640.10 UniProtKB/Swiss-Prot
  Laminin UniProtKB/Swiss-Prot
InterPro EGF-like_dom UniProtKB/Swiss-Prot
  Haem_peroxidase_animal UniProtKB/Swiss-Prot
  Haem_peroxidase_sf UniProtKB/Swiss-Prot
  Haem_peroxidase_sf_animal UniProtKB/Swiss-Prot
  Oxylipin_biosynth_metab UniProtKB/Swiss-Prot
KEGG Report rno:29527 UniProtKB/Swiss-Prot
NCBI Gene 29527 ENTREZGENE
PANTHER PROSTAGLANDIN G/H SYNTHASE UniProtKB/Swiss-Prot
  PTHR11903:SF8 UniProtKB/Swiss-Prot
Pfam An_peroxidase UniProtKB/Swiss-Prot
  EGF UniProtKB/Swiss-Prot
PharmGKB PTGS2 RGD
PhenoGen Ptgs2 PhenoGen
PRINTS ANPEROXIDASE UniProtKB/Swiss-Prot
PROSITE EGF_3 UniProtKB/Swiss-Prot
  PEROXIDASE_3 UniProtKB/Swiss-Prot
RatGTEx ENSRNOG00000002525 RatGTEx
Superfamily-SCOP EGF/Laminin UniProtKB/Swiss-Prot
  SSF48113 UniProtKB/Swiss-Prot
UniProt A0A8A1UB91_RAT UniProtKB/TrEMBL
  A0ABK0LMM3_RAT UniProtKB/TrEMBL
  A6ICR0 ENTREZGENE, UniProtKB/TrEMBL
  A6ICR1_RAT UniProtKB/TrEMBL
  P35355 ENTREZGENE, UniProtKB/Swiss-Prot
  Q63124 ENTREZGENE, UniProtKB/TrEMBL
  Q64379 ENTREZGENE
  Q925V4 ENTREZGENE
UniProt Secondary Q64379 UniProtKB/Swiss-Prot
  Q925V4 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2004-12-14 Ptgs2  prostaglandin-endoperoxide synthase 2      Symbol and Name status set to approved 1299863 APPROVED
2002-08-07 Ptgs2  prostaglandin-endoperoxide synthase 2      Symbol and Name status set to provisional 70820 PROVISIONAL

RGD Curation Notes
Note Type Note Reference
null catalyzes the generation of prostaglandins from arachidonic acids  
null catalyzes the generation of prostaglandins from arachidonic acids 628427
gene_disease highly expressed in neurodegenerative disorders 625680
gene_drugs ketorolac, a water-soluble and nonselective inhibitor blocks the enzyme activity, but it can increase gene expression in cells of the blood-brain barrier 625680
gene_expression expressed in kidney 70545
gene_expression expressed in specialized tissues like ovarian granulosa cells, macrophages, endothelium, and seimnal vesicles; developmentally regulated expression pattern 625680
gene_function catalyzes conversion of arachidonic acid to prostaglandin H2 625680
gene_function acts both as a deoxygenase and peroxidase 625680
gene_process may function in the metabolism of arachidonic acid into prostanoids 70545
gene_process has a role in renal salt and water excretion 70545
gene_process major medaitor of inflammatory responses 625680
gene_process major medaitor of inflammatory responses 628427
gene_process may be a cytokine regulator in Leydig progenitor cells 625680
gene_process key enzyme in prostaglandin biosynthesis 625680
gene_regulation expression in the juxtaglomerular apparatus during low-salt diet is greatly reduced by a direct feedback inhibition through ANG II 625680
gene_regulation mRNA and protein expressions increases in alpha-beta-methyleneATP-induced gliosis and is dependent on ERK1/2 but independent of calcium signaling 625680
gene_regulation induced by interleukin 1 beta in Leydig cells 625680